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ABSTRACT
PORPHYROMONAS GINGIVALIS INFECTION IN GESTATIONAL DIABETES
MELLITUS AND SURVIVAL IN TOBACCO SMOKERS
Himabindu Gogeneni
July 28, 2017
This thesis contains a clinical project and distinct basic science project.
Gestational diabetes mellitus occurs in 4% of pregnancies and increases the risk of birth
defects, pre-term birth, and miscarriage. Gingivitis during pregnancy also increases the
risk for poor pregnancy outcome. Gingivitis is a bacterial-induced disease, and specific
plaque pathogens have been associated with systemic sequelae to periodontal
inflammation. Therefore, we set out to monitor oral infection with three key
periodontopathogens (Porphyromonas gingivalis, Filifactor alocis, and Treponema
denticola) and the systemic inflammatory burden [C-reactive protein (CRP)] in pregnant
women with and without gingivitis and gestational diabetes. Gingivitis during pregnancy
leads to a dramatic increase in systemic CRP (mean 8116 vs. 2495 ng/ml, p < 0.01), as
determined by Enzyme Immunoassay (EIA). As expected, gingivitis during pregnancy was
associated with oral infection with P. gingivalis, F. alocis and T. denticola and
combinations thereof (all p < 0.01), as determined by salivary PCR. Gestational diabetes
mellitus was also associated with increased infection with individual and multiple
periodontopathogens, including P. gingivalis. Thus, diabetes and gingivitis act in concert
to increase risk biomarkers for poor pregnancy outcome. Actual pregnancy outcomes in
the study population are currently being monitored.
iv

The majority of cases of chronic periodontitis in developed nations are tobacco-related.
For periodontal pathogens, such as P. gingivalis, to induce or exacerbate periodontal
diseases in smokers, they must first be able to survive the highly complex composite toxic
insult represented by cigarette smoke. While it is clear that P. gingivalis is resistant to
highdoses of cigarette smoke and tobacco constituents, the survival mechanisms are
entirely unknown. Therefore, we first generated a P. gingivalis ATCC 33277 transposon
sequencing (Tn-Seq, Library 1) and determined the putative minimal essential genome for
in vitro growth in complex media in conjunction with a separate P. gingivalis ATCC 33277
Tn-Seq library generated by Klein et al. (Library 2). In all, 281 genes (61%) identified by
Library 1 were common to Library 2. Many of these common genes are involved in crucial
metabolic pathways, notably pyrimidine cycling as well as lipopolysaccharide,
peptidoglycan, pantothenate and coenzyme A biosynthesis, and nicotinate and
nicotinamide metabolism. Also in common are genes encoding heat-shock protein
homologs, sigma factors, enzymes with proteolytic activity, and the majority of Sec-related
protein export genes. In addition to facilitating a better understanding of critical
physiological processes, transposon-sequencing technology has the potential to identify
novel strategies for the control of P. gingivalis infections. Those genes defined as essential
by two independently generated TnSeq mutant libraries are likely to represent particularly
attractive therapeutic targets.
Next, we tested Library 1 for genes essential for the survival of exposure to cigarette
smoke extract. Of the 2155 P. gingivalis ATTCC 33277 genes, 257 (8%) were found to be
essential for growth upon cigarette smoke exposure. The essential genes were distributed
throughout the bacterial genome. Genes with products that function in DNA metabolism,
energy metabolism, signal transduction, protein fate and transport and binding proteins
were best represented within the essential gene set. In a competition assay of the mutants
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of genes of biological interest, the following mutants were outcompeted by the wild type,
P. gingivalis ATCC 33277 strain: PGN_1524 encoding uncharacterized protein,
PGN_1474 (luxS) encoding S-ribosyl homocysteine lyase, PGN_1200 encoding putative
ATPase,PGN_1444 (carA) encoding carbamoyl- phosphate synthase small chain,
PGN_0770

(rnz)

encoding

ribonuclease

Z,

PGN_0714

encoding

probable

pyrazinamidase/ nicotinamidase, PGN_0491 encoding probable phosphotyrosine protein
phosphatase , PGN_0287 (mfa1) encoding minor fimbrium subunit Mfa1 , PGN_0088
encoding putative transcriptional regulator, and PGN_0388 (tpx) encoding putative thiol
peroxidase. We confirmed the respective gene fitness in a Gifu anaerobic media
conditioned with cigarette smoke extract (GAM-CSE) model. Further competition assays
of the top 10 genes in the identified gene list, according to the fold change and
complementation assays, could provide some of the first insights into how cigarette smoke
changes the P. gingivalis phenotype in a manner likely to promote colonization and
infection. Those genes identified as conditionally essential are likely to represent attractive
therapeutic targets to combat P. gingivalis infection in smokers.
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CHAPTER 1
INTRODUCTION
Next to dental caries, periodontal diseases are the most prevalent oral diseases in the
world, affecting 10-15% of adult population, according to the WHO [1]. According to the
CDC report, 47.2% of adults in the United States aged 30 years and older have some form
of periodontal disease [2]. Periodontal diseases refers to inflammation of the periodontium,
the supporting tissues of the tooth, and are the leading causes of tooth loss [3]. Clinically,
periodontal diseases are characterized by gingival inflammation, gingival bleeding, and
increased periodontal pocket depth [4]. According to the American Academy of
Periodontology, periodontal diseases are broadly classified as gingivitis and periodontitis
[5]. Gingivitis is the inflammation of gingiva without any bone loss, usually associated with
the presence of bacteria. Periodontitis is defined as inflammation of the gingiva extending
into the adjacent attachment apparatus of the tooth [6]. Chronic periodontitis is the most
prevalent form of periodontitis and has been associated with increased prevalence of
diabetes mellitus, AIDS, leukemia, down’s syndrome, cardiovascular diseases,
rheumatoid arthritis and pre-term low birth weight babies [7-11]. Chronic periodontitis is
multifactorial, and its pathogenesis is characterized by the interaction of host (genetics),
agent (oral biofilm), and environmental (patient behaviors like smoking, medications or
systemic diseases) [3]. The pre-requisite for the development of the periodontal diseases
is the presence of pathogenic biofilms [12].
1.1. Oral biofilm:
Oral biofilm is defined by Costerton et al., as a structured community of bacterial cells
enclosed in self-produced polymeric matrix and adherent to an inert or living surface. The
first step in the oral biofilm formation process is the formation of the salivary pellicle, a thin
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acellular film that forms on any surface upon exposure to saliva, providing a niche for the
colonization of microorganisms through autogenic succession. Further oral bacteria
secrete mucin, albumin, glycoproteins, acidic proline-rich proteins, etc. which form the
matrix of the biofilm [13]. The microbes that colonize by adhering to salivary pellicle and
initiate biofilm formation are primary colonizers. Primary colonizers are mainly
commensals of the oral cavity such as Gram-positive bacilli and cocci including
Streptococcus sanguis, Streptococcus oralis, Streptococcus mitis and Actinomyces
viscosus. If left undisturbed, the primary colonizers promote the colonization of more
pathogenic late colonizers such as Treponema denticola, Porphyromonas gingivalis and
Tannerella forsythia [14, 15]. The biofilm is formed through a coordinated process,
supporting a broad range of bacteria by providing a favorable niche for the periodontal
pathogens [16]. The presence of certain species like P. gingivalis leads to dysbiosis,
resulting in periodontal destruction [17]. However, the presence of biofilm alone is not
sufficient to cause periodontal diseases [18]. Host immune response to these pathogens
plays a crucial role in the periodontal tissue destruction.
According to the polymicrobial synergy and dysbiosis (PSD) model, oral dysbiosis plays a
crucial role in the pathogenesis of periodontal diseases. P. gingivalis, which is considered
a keystone pathogen, alone failed to induce bone loss in germ-free mice but was able to
induce bone loss when combined with other oral commensals [19]. P. gingivalis plays a
crucial role in the pathogenesis of periodontitis by altering the oral biofilm composition and
the host immune response to these altered biofilms [20, 21]. As per PSD model,
periodontitis is believed to be initiated by synergistic and dysbiotic microbial communities
[21]. Dysbiosis is characterized by the relative abundance of pathobionts, commensals of
the biofilm that under certain conditions can cause pathology [22, 23], compared to
commensals in the biofilm. The results of human clinical studies are in agreement with the
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observations identified in animal models regarding the PSD model. Clinically, it has been
shown that in the case of periodontal diseases, there is a decrease in the commensal
organism Streptococcus sanguis [24, 25]. The results of transcriptional profiling of
microbial samples from periodontally healthy versus diseased sites have demonstrated
that the majority of potential virulence factors upregulated in human disease are derived
from the bacteria associated with periodontal health [26]. Many recent studies, using
Human Microbiome Project data set as a reference, have shown the difference in the
biofilm structure and its functional capacities [27-30]. Studies involving recent
advancements like 16S rRNA and shotgun sequencing have also confirmed the existence
of significant differences in microbial communities between healthy and periodontal
disease individuals [28-31]. This finding is further confirmed by the case-control study
performed using Illumina Miseq Desktop Sequencing of subgingival samples [27, 32].
Cluster analysis by principal component analysis showed that the bacterial communities
were different in healthy and periodontally diseased groups; Porphyromonas, Treponema,
and Filifactor species were significantly enriched in the diseased group. Also, it has been
shown that the chronic periodontitis sites contained greater microbial diversity and species
richness compared to healthy control sites [27, 32].
In an oral biofilm, oral microorganisms interact through inter-microbial adhesion, cell
signaling using cell-to-cell contact. Metabolic communications, including quorum sensing,
also play a major role in maintaining the integrity of oral biofilm and an essential role in
microorganism survival [33, 34], leading to coordinated gene expression within the
microbial community that in turn influences the pathogen’s ability to cause disease [35,
36]. Metatranscriptome analysis studies showed that there to be overexpression of
biological functions related to flagellar motility, peptide transport, iron acquisition, betalactam degradation and the biosynthesis of the lipid A component of endotoxins in the
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dental biofilms collected from active periodontal sites [26, 37]. Thus, in an individual with
periodontitis, there is altered expression of genes related to particular physiological
processes that help the microbes to survive in the changed environmental conditions of
the dysbiotic biofilm . Further, these dysbiotic biofilms can lead to chronic inflammation by
stimulating the host inflammatory response [21, 38].
In summary, periodontal diseases may be triggered by a conglomeration of several
bacterial species, rather than a single pathogen, and be dependent on the microbial
communities and their interactions. Dysbiosis of oral biofilms plays a crucial role in the
pathogenesis of periodontal diseases by aggravating the host immune response to oral
biofilms, leading to inflammation and bone loss [39]. Local environmental changes such
as increased gingival inflammation, bleeding on probing, and increased periodontal pocket
depth periodontal also alter bacterial gene expression related to survival fitness of the
microbes in the biofilms. While most organisms in the subgingival microbiota are
considered commensals, several bacteria have been implicated as periodontal pathogens
including Porphyromonas, Treponema, and Filifactor. However, P. gingivalis and T.
denticola were found in both healthy and periodontally diseased individuals. In this study,
we are interested in studying P. gingivalis, T. denticola, and F. alocis as they have shown
a strong association with periodontal diseases.
1.2. Treponema denticola:
T. denticola is a Gram-negative bacterium from the Spirochetes family. It is motile,
slender, helically-shaped, and flexible. It has been routinely isolated from human
subgingival plaque and is strongly associated with changes in the subgingival ecology
characteristic of disease sites [40-42]. T. denticola is considered as one of the main
etiological agents for periodontitis [41, 43]. In contrast to the wide diversity of phylotypes
in healthy sites, only a few phylotypes are found in diseased sites [44]. T. denticola can
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lyse and damage periodontal cells, adhere to epithelial cells and ﬁbroblasts, co-aggregate
to bioﬁlm-bridging organisms, and can produce proteins and polypeptides that interact
with the host immune response [40]. In vitro studies have shown that components of T.
denticola can induce a range of pro-inflammatory cytokines such as interleukin 1(IL-1),
tumor necrosis factor (TNF), IL-6 and IL-8 [45]. It has been found that the proportion of T.
denticola increases significantly in periodontal disease biofilms. T. denticola is typically
detected together with other pathogens P. gingivalis and T. forsythia [46]. In murine
models of periodontitis, synergy between organisms has been demonstrated by
inoculation of animals with P. gingivalis together with either T. denticola or T. forsythia,
resulting in more extensive alveolar bone destruction than inoculation with a single species
[47, 48]. Thus, the prevalence of T. denticola in periodontal pockets, together with high
numbers of other proteolytic Gram-negative bacteria, may play a major role in the
progression of periodontal disease. One of the challenges of researching treponemes,
such as T. denticola, is the difficulty of their cultivation in vitro. T. denticola requires the
presence of fibronectin coating to facilitate its attachment, and it is difficult to obtain a
model system for biofilm growth for pure cultures of T. denticola [49]. Hence little work has
been done on T. denticola biofilm growth.
1.3. Filifactor alocis:
Recent advances in sequencing techniques have allowed the identification of
microorganisms within the subgingival dental biofilm, which had previously been
unrecognized because of culture difficulties. F. alocis has been identified as potential
pathogen in recent non-culture based studies [27, 50]. F. alocis is a fastidious, Grampositive, obligately anaerobic rod. It is considered to be an important pathogen in the
formation of subgingival biofilm and the onset of periodontal diseases [31]. Owing to its
high prevalence and abundance in periodontal disease sites compared with healthy sites,
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it is considered as a potential marker for active disease [27, 51, 52]. F. alocis is relatively
resistant to oxidative stress and possesses several virulence factors, such as
sialoglycoproteins, proteases, adhesion molecules, neutrophil-activating protein A, and a
calcium-binding acid repeat protein [31]. F. alocis can stimulate the production of host proinflammatory cytokines IL-1β, IL-6, and TNF, which in turn can stimulate pathways that
activate osteoclasts and increase alveolar bone resorption [53, 54]. F. alocis can also
interact with other oral bacteria and form biofilms [55]. F. alocis has also been shown to
enhance the virulence or the growth of other pathogens, promoting the pathogenesis of
periodontitis [31]. For example, F. alocis synergistically interacts with P. gingivalis [56],
enhancing biofilm formation and invasion of epithelial cells by when in coculture. F. alocis
also interacts synergistically with F. nucleatum in vitro [57]. It was previously shown that
F. alocis is involved in numerous spatial arrangements with other organisms, indicating its
role as one of the architects of structural organization within periodontal biofilms [55].
1.4. Porphyromonas gingivalis:
P. gingivalis is a Gram-negative, black-pigmented, obligately anaerobic organism, and the
most studied of the periodontal pathogens. This species was found in 85.75% of
subgingival plaque samples from patients with chronic periodontitis [58]. Colonization
by P. gingivalis is also associated with some systemic diseases, including cardiovascular
diseases, rheumatoid arthritis, and Alzheimer's disease [59-61]. Its occurrence is higher
in subjects with chronic periodontitis compared to periodontally healthy subjects [62, 63].
P. gingivalis is considered to be a keystone pathogen in the pathogenesis of periodontitis,
due to its disproportionate influence on the microbiome in relation to its abundance [17,
64]. P. gingivalis was identified as a keystone pathogen in a study using a combination of
culture-based methods and next-generation sequencing( NGS) [65]. Human studies have
also shown that P. gingivalis is present in low abundance when compared with the total
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oral microbiota in disease sites [52]. P. gingivalis benefits from a variety of interactions
with other bacteria under deprived oxygen conditions. Studies have also demonstrated
that P. gingivalis can be present in the subgingival biofilm and colonize the epithelium in
healthy individuals [66, 67]. In vivo studies have shown that even though P. gingivalis is
present in low numbers, its presence enhances the growth of pathogenic microflora which
in turn leads to periodontal diseases [19]. On its own, P. gingivalis does not induce disease
in germ-free mice, yet it can shift the balance of microflora in oral cavity towards a more
pathogenic community, resulting in periodontal diseases. Thus pathogenicity of P.
gingivalis is related not only to its physiological state but also to its interactions with other
oral microflora [22].
The means by which early colonizers facilitate colonization by P. gingivalis include the
provision of attachment sites for adherence, the supply of growth substrates, and
reduction of oxygen tension to the low levels required for growth and survival [68]. P.
gingivalis can adhere to both early and late colonizers of oral biofilm. P. gingivalis plays a
crucial role in the autogenic succession of oral microflora towards more Gram-negative
bacteria leading to dysbiosis [28, 62, 69]. In a mouse model, it has been shown that,
despite low numbers, P. gingivalis created dysbiotic changes in the oral biofilm. Further,
it has been shown that dysbiosis can be triggered by keystone pathogens such as P.
gingivalis and is characterized by an increase in the prevalence of pathobionts [24, 25,
70]. A recent study also proved the concept of keystone pathogen-mediated (P. gingivalis)
PSD model to explain the etiology of periodontitis [71].
In vitro studies revealed that P. gingivalis produces a wide array of putative virulence
factors including fimbriae, capsules, lipopolysaccharide (LPS), lipoteichoic acids,
hemagglutinins, gingipains (secreted proteases), outer membrane proteins, and outer
membrane vesicles [72, 73]. However, the mere presence of virulence factors itself is not
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sufficient to induce attachment and bone loss. Host immune response to these virulence
factors, and to the bacteria as a whole, plays a crucial role in the pathogenesis of
periodontitis [74, 75]. The virulence factors of P. gingivalis are known to suppress the host
immune response, thus promoting the growth of commensals in the oral biofilm [39]. In
vitro studies have shown that P. gingivalis can induce proinflammatory cytokines such as
IL-1α, IL-1β, TNF, IL-6, and IL-8 [76, 77]. A study by Guentsch et al., showed that
extracellular release of reactive oxygen species (ROS) by neutrophils occurred when
exposed to P. gingivalis. This phenomenon may lead to destruction of the bacteria and
damage to the surrounding periodontal tissue. P. gingivalis can also upregulate the
collagen-degrading ability of some human gingival fibroblast (HGF) cell lines [78], thus
may have a role in enhancing periodontal tissue degradation in vivo.
1.5. P. gingivalis virulence factors:
Fimbriae
The fimbriae of P. gingivalis are thin, filamentous, cell surface protrusions. Two classes of
fimbriae exist, Type I (major) fimbriae and type II (minor) fimbriae. Type I (major) fimbriae
have significant roles in colonization and invasion, whereas type II (minor) fimbriae
possess a higher pro-inflammatory capacity [79-81]. Fimbrillin, a protein in the major
fimbriae, is encoded by fimA gene. This gene was classified into six genotypes according
to its genomic differences [82, 83]. fimA type I was associated with periodontal health.
Genotype II has greater adhesive and invasive properties, has been observed to be more
prevalent in periodontal patients, and is associated with more aggressive forms of
periodontal disease. In mouse models, type I and III induced weak inflammation whereas
type II, Ib, IV, and V induced strong inflammation [84]. In experimental periodontitis
models, fimbriae induced bone destruction. In rat models, infection with nonfimbriated P. gingivalis strains exhibited reduced periodontal bone loss, compared with
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infection with fimbriated strains [85]. Immunization against P. gingivalis fimbriae protected
against bone loss in gnotobiotic rats [86]. Other properties of both major and minor
fimbriae include the induction of pro-inflammatory cytokines and production of matrix
metalloproteinases (MMPs), such as IL-1, IL-6, IL-8, TNF, and MMP-9, by various host
cells [87-89]. P. gingivalis fimbriae can signal through either TLR2 or TLR4. Activation of
TLR2 by fimbriae results in a distinctive signaling pattern compared with activation
by P. gingivalis LPS [90]. The differential signaling pattern, in turn, activates the binding
capacity of CR3 and allows for internalization of P. gingivalis in macrophages and
reduction of IL-12 production, which may collectively inhibit bacterial clearance [91].
Proteases
Proteases were classified as serine, cysteine, and metalloproteinase depending on the
catalytic mechanisms. These include gingipains (Arg- or Lys-), periodontain (cysteine
endopeptidase), PrtT proteinase, Tpr proteinase, collagenase (prtC gene), prolyl
tripeptidyl peptidase (serine exopeptidase), dipeptidyl-peptidase IV (serine exopeptidase
known as glycylprolyl peptidase, a product of the dppIV gene), dipeptidyl-peptidase VI
(putative cysteine exopeptidase), amino-peptidase P, oligo-peptidase O and gelatinase (a
proteinase degrading type IV collagen, gelatin, low-molecular-mass-kininogen and
transferrin) [92]. Of these, the collagenases, aminopeptidases, and the trypsin-like
proteases are critical to P. gingivalis pathogenesis [72].
P. gingivalis, an asaccharolytic organism, expresses a set of trypsin-like proteases that
degrade proteins to use as an energy source, for processing of P. gingivalis proteins such
as fimbriae and also potentiates inflammation [93, 94]. Gingipains are cysteine proteases
that can cleave the proteins at arginine and lysine specific sites [95]. A variation on the
genotype level of the proteolytic enzymes (gingipains) has been reported [96, 97]. P.
gingivalis produces Lys-X and Arg-X peptide bonds specific proteases (Kgp, RgpA, and
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RgpB gingipains) which are considered as a major virulence determinant. The activation
of inflammation is part of a basic survival strategy, increasing the protein-rich gingival
crevicular fluid bathing the gingival sulcus while dampening killing mechanisms in
phagocytic cells [98]. Three types (type A, B, and C) of the Arg-specific cysteine
proteinase-encoding genes (prpR1/rgpA) and two (type I and II) of the Lys-specific
cysteine proteinase-encoding genes (kgp) were identified in these studies. These
gingipains can up-regulate MMP-8 and MMP-3 expression in rat mucosal epithelial cells
and activate latent MMPs [99, 100]. MMPs activation may, in turn, induce connective
tissue and bone destruction leading to periodontitis [74]. Gingipains also deregulate the
various components of the immune response [101] which, in turn, hampers bacterial
clearance and facilitates bacterial invasion.
Capsule
The capsule is another important virulence factor of P. gingivalis [102, 103]. Six different
serotypes of capsules have been identified depending on capsular polysaccharide Kantigens and their capacity to generate systemic IgG antibodies [104]. Bacterial
encapsulation is positively correlated with increased resistance to phagocytosis [105]. In
comparison to non-encapsulated strains, encapsulated P. gingivalis strains are shown to
be highly invasive, causing spreading infection in a murine lesion model and more
resistance to phagocytosis by PMN [106, 107]. P. gingivalis capsule polysaccharide
(CPS) mutant strain was found to be a more potent inducer of cytokine synthesis by human
gingival fibroblasts compared with the corresponding wild-type strain. Thus CPS hampers
the innate immune response [102, 103]. In an animal model, immunization with P.
gingivalis capsule resulted in a decrease in alveolar bone loss induced by P. gingivalis
[108].
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Lipopolysaccharide (LPS)
LPS is a cell wall component of Gram-negative bacteria and is composed of O-antigen,
core polysaccharide and lipid A. Lipid A exists predominantly in two forms in P. gingivalis
- the tetra-acylated and penta-acylated forms. The penta-acylated lipid A activates TLR4,
whereas tetra-acylated lipid A acts as a TLR4 antagonist [109, 110]. P. gingivalis LPS is
thus a weaker cytokine stimulator compared with that of other Gram-negative bacteria. In
vitro, it stimulates the production of pro-inflammatory cytokines such as IL-1α, IL-1β, IL-6,
IL-8, IL-18 and TNF in monocytes [75, 111-113]. In animal models, it has been shown that
P. gingivalis LPS triggers pro-inflammatory responses and bone resorption in the oral
cavity [114]. In summary, P. gingivalis LPS leads to host immunological deregulation, thus
facilitating the P. gingivalis adaptation and survival.
Recent studies showed that the expression of virulence factors of P. gingivalis is regulated
in response to environmental changes. To ensure optimal nutrient uptake in response to
environmental changes, P. gingivalis adopts various methods to utilize iron and heme
[115]. It was found that fimA gene expression was decreased by approximately 50% in
response to hemin limitation and the presence of serum or saliva in the growth medium
[116]. Environmental conditions influence the changes in P. gingivalis lipid A acylation.
Penta-acylated lipid A is converted into tetra-acylated lipid A when there is inflammation
(high hemin availability), thus modulating host immune response [117]. Thus, P. gingivalis
adapts to the environmental changes in the oral cavity for its survival within the host.
1.6. Host influence on P. gingivalis
Clinically periodontal diseases are characterized by gingival inflammation, bleeding on
probing and increased pocket depth. Apart from the host immune response, bacterial
adaptation to these local host environmental changes also plays a significant role in
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survival and towards the pathogenesis of periodontal diseases [118]. It has been shown
in many studies that P. gingivalis can alter expression of several genes in response to
varied environmental conditions as a part of its survival strategy.
In response to a change in pH or temperature, P. gingivalis alters the biophysical
properties of its membrane lipids [22]. Despite being anaerobe, P. gingivalis is microaerotolerant. It has been shown that on exposure to oxygen, P. gingivalis adapts to the
aerobic conditions through upregulation of genes encoding adhesins and phosphatases,
and the downregulation of protease-encoding genes and proteins interfering with
adhesion [119]. On exposure to atmospheric oxygen, there is upregulation of genes
involved in oxidative stress, and in virulence factors involved in heme acquisition,
presumably as a protective mechanism against the molecular oxygen and the reactive
oxygen species [120]. Heme is an essential nutrient for P. gingivalis survival. In a
combined quantitative proteomic and transcriptomic analysis study, it has been shown
that P. gingivalis upregulates the production of several proteins linked to metabolism,
oxidative stress response, virulence, and invasion of host cells to cope

with heme

limitation [121]. In vivo studies have shown that the expression of virulence factors in P.
gingivalis increase after hemin limitation [121, 122]. The heme-binding lipoprotein HmuY,
GAPDH and some of the cell-surface-located C-terminal domain (CTD) family proteins,
including RgpA, HagA, CPG70, and PG99, are increased in biofilm cells. Concurrently,
the heme-binding protein IhtB, TonB-dependent receptor P92, Kgp, lipoprotein RagB,
endopeptidase PepO, a glutamine cyclotransferase-related protein, fumarate reductases
FrdAB, and ribosomal proteins L10, L13 and L25 are significantly decreased. There is a
differential response of P. gingivalis to varying concentrations and durations of hydrogen
peroxide [123]. As a response to shorter exposure to H2O2-induced oxidative stress, genes
involved in DNA replication, recombination and repair were upregulated [123, 124]. After
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a longer exposure, several genes involved in protein folding/repair were upregulated
whereas those involved in translation were downregulated. Thus, P. gingivalis is capable
of sensing and rapidly responding to changes in its environment.
1.7. P. gingivalis strains:
Different clones of P. gingivalis in subgingival plaque samples have been found [125, 126].
In “Java Project on Periodontal Disease”, a longitudinal study performed over a span of 8
years to investigate the clonal stability of P. gingivalis [127], 24 P. gingivalis genotypes
were detected that occurred in one subject only. This heterogenicity among P. gingivalis
strains might arise due to mobile genetic elements such as many insertional sequences
(IS) and transposons; pathogenic islands like the rag locus [128-130]. Genetic variation
also arises as a consequence of conjugal transfer leading to allelic exchange in P.
gingivalis [131-133].
The rag locus, a novel pathogenicity island, encodes RagA and RagB, entities that
constitute a membrane transport system. RagA is an 115-kDa TonB-dependent outer
membrane receptor, and RagB is a 55-kDa lipoprotein constituting an immunodominant
outer antigen [134]. Several studies suggested the virulence of rag locus. In a study
conducted in Columbia, 32 P. gingivalis isolates were analyzed and shown to contain a
greater bacterial diversity due to the rag locus. Four rag locus P. gingivalis variants differ
in their pathogenicity [134-136]. P. gingivalis carrying rag-1, rag-3 was more predominant
in chronic periodontitis patients in Northeast China [137]. P. gingivalis- rag locus gene
mutants show reduced virulence in a mouse model study [138].
P. gingivalis strains are classified as invasive or non-invasive strains based on differences
in the ability to cause soft-tissue abscesses following subcutaneous injections at distant
or local sites [139]. Different strains were also identified depending on their capacity to
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cause periodontal bone loss, serum and saliva antibody expression and death in mice
[140-142]. A difference in both alveolar bone resorption and the systemic acquired
immune response was also found among different strains of P. gingivalis [143, 144].
In summary, several strains of P. gingivalis have been identified. Chronic periodontitis is
not associated with a particularly virulent clonal type [145]. ATCC 33277 is one of the most
commonly employed strains in periodontal research. It is pathogenic in experimental
animals following oral infection [146]. Thus, we used P. gingivalis ATCC 33277 strain in
our study in chapter 3.
1.8. P. gingivalis ATCC 33277 genome:
Naito et al. presented the whole genome sequence of P. gingivalis ATCC 33277[147]. The
genome of ATCC 33277 comprised a single circular chromosome of 2,354,886 bp with an
average G + C content of 48.4% [147]. The ATCC 33277 genome contained 2155 genes,
2090 protein coding sequences (CDSs) with a mean size of 970 bp, covering 86.1% of
the whole chromosome sequence, approximately 117,000 TA sites, and no plasmids [32,
147, 148]. It contains 4 RNA operons and 53 tRNA genes that provide specificity for amino
acids. ATCC 33277 contained a variety of mobile genetic elements [147]. Only four NCBI
annotated genes coding hypothetical proteins lack TA sites [148]. A total of 93 insertion
sequence elements and 48 miniature inverted-repeat transposable elements were found
in ATCC 33277. Insertion sequences are the simplest transposable elements, encoding a
transposase and can be as short as 600–700 bp. The insertion sequence elements
identified in ATCC 33277 were classified into six types, ISPg1–ISPg6, all of which are also
present in W83 [149].
Apart from ATCC 33277, the complete genome sequence of the strains W83, HG66,
TDC60, and JCVISC001 are known. Three copies of 16S rRNA sequences in HG66 are
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identical to the four copies of 16S rRNA sequences in ATCC 33277, suggesting a close
evolutionary lineage between HG66 and ATCC 33277. Genome-wide comparisons based
on Rapid Annotation using Subsystem Technology (RAST) also showed that for the
overall biological functions of the genomes, ATCC 33277 is closer to HG66 compared to
other strains. By comparing genome sequences of ATCC 33277 and W83 strains, 461
ATCC 33277-specific and 415 W83-specific predicted protein coding sequences were
identified. Between the two strains, 175 regions with genomic rearrangements were
observed. These rearrangements occurred as a result of various mobile genetic elements
such as insertion sequences, miniature inverted-repeat transposable elements,
transposons, and conjugative transposons (CTns) [147].
In summary, the expression of virulence factors by the periodontal pathogen is often
regulated in response to changes in the external environment. In the subgingival area,
bacteria experience dramatic environmental changes resulting from host eating and oral
hygiene patterns, gingival crevicular flow rate variability, and the degree of bleeding. In
response to these dynamic processes, bacteria often regulate gene expression to
maintain optimal phenotypic properties. Many studies have shown that each virulence
factor plays important roles to hamper the cell-mediated immune response in the host.
However, in the host, the bacteria express a whole subset of virulence factors rather than
any single virulence factor. Thus, analysis of the bacterial genome is crucial to understand
the properties and role of virulence factors as a whole. In chapter 2, the generation of a P.
gingivalis ATCC 33277 transposon mutant library is described. We compared the
generated library with the TnSeq library generated by Klein et al., to identify the common
inherently essential genes in P. gingivalis ATCC 332777 strain. Further, the generated
mutant library can be tested under various experimental conditions to investigate the
conditional genes essential for P. gingivalis survival in those conditions.
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In a susceptible host, dysbiosis can trigger abnormal host responses leading to the
destruction of periodontal tissues and periodontal diseases [6, 150, 151]. The hostbacterial interactions are estimated to account for almost 80% of the risk of periodontal
tissue damage [152]. A potentially virulent microbe remains avirulent in an insusceptible
host. Thus, the presence of variable complex microbial patterns in a susceptible host and
the inflammatory immune response plays a significant role in the outcome of periodontal
diseases. The result of this interaction is, in turn, dependent on many other risk factors
including smoking, systemic conditions such as gestational diabetes mellitus (GDM), and
other factors including age, gender, and socioeconomic status.
1.9. Periodontal diseases and tobacco smoking:
Cigarette smoking is strongly associated with multiple diseases, including lung cancer,
chronic obstructive pulmonary disease, heart disease, respiratory infection, and
periodontitis [153-156]. It is considered to be the single major preventable environmental
risk factor for chronic periodontitis through its influence on the microbial composition of
the biofilm [28, 62, 157, 158] and the host immune system [155].
Smoking-related periodontitis is a significant global public issue, as there are >1 billion
adult smokers worldwide. Approximately half of the periodontitis cases in the U.S.A. could
be attributable to smoking, and current smokers were about four times more likely to be
diagnosed with periodontitis than never smokers [159]. Smokers are refractory to
periodontal treatment compared to non-smokers [160]. Cross-sectional studies have
shown that smokers are two to seven times more likely to present with periodontitis,
compared to non-smokers [159, 161]. Clinical studies have demonstrated that smokers
have the more severe periodontal disease [162-164]. A recent country wide
epidemiological study conducted in Sweden suggested a strong association between
smoking and moderate and severe alveolar bone loss overall [165]. In a cohort study
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carried out in New Zealand, it has been found that the extent and prevalence of alveolar
bone loss was greater in smokers compared to never smokers and former smokers [166].
In a large population-based prospective cohort study of men and women in the state of
Brandenburg, Germany, a strong dose-dependent association between cigarette smoking
and the prevalence and incidence of tooth loss has been found. This association is
independent of other risk factors and potential confounders [167]. In studies, conducted
using cloning and sequencing methods, smokers are associated with higher prevalence
of periodontal pathogens compared to non-smokers [168]. In a Dunedin birth cohort study,
investigators followed up people born in 1973. They confirmed the strong association
between chronic smoking and periodontal disease [169].
Tobacco smoke contains over 7000 different chemicals, including carbon monoxide,
hydrogen cyanide, reactive oxidizing radical. Sixty of these chemicals are known or
suspected carcinogens [170] and the most abundant alkaloid is nicotine . Tobacco smoke
contains carbon monoxide which will lower the oxygen saturation of hemoglobin in healthy
gingiva resulting in a significant reduction of oxygen tension within the periodontal pockets
in smokers [171]. This decrease in oxygen tension may favor the growth of anaerobic
bacteria, even in the shallower pockets. Periodontitis is caused by over-expression of proinflammatory cytokines and inflammatory mediators at the periodontium. In smokingassociated periodontitis, bone loss occurs because of various osteolytic mediators such
as IL-1β, IL-8, RANKL, MMP-2, MMP-9, and tPA.
1.9.a. Smoking and the host immune response to oral microorganisms:
The susceptibility of epithelial cells, the mechanical protective barriers of the tissue, to
become colonized by periodontal pathogens is modulated by smoking [172]. In an in vitro
study, it has been shown that cigarette smoke could impair epithelial innate immune
responses to microbial products, allowing overgrowth and invasion [173]. Nicotine can
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suppress osteoblast proliferation while stimulating alkaline phosphatase activity,
enhancing the bone loss. The ability of tobacco products to decrease the proliferative
capacity of T and B lymphocytes might contribute to this diminished production of
protective antibodies [174]. Nicotine induces pathological changes in human periodontal
tissue, resulting in altered morphology and structure of host cells, decreased bone volume,
and tooth loss [163, 175-177]. Cigarette smoke also reduces the host response to
periodontopathic bacteria, resulting in a more destructive periodontitis [178]. Numerous
functions of oral or peripheral neutrophils are negatively affected by smoking or nicotine
exposure, including phagocytosis, superoxide, and hydrogen peroxide generation, integrin
expression, and protease inhibitor production [179]. Because of down-regulation of antiinflammatory factors along with an upregulation of pro-inflammatory cytokines, there might
be increased infection risk by periodontal pathogens in smokers. Smokers are susceptible
to colonization by P. gingivalis, a causative agent of periodontitis [180].
1.9.b. Smoking and oral microflora:
There are conflicting reports on the effects of smoking on oral microflora with some studies
reporting no differences between smokers and non-smokers in the detection of periodontal
pathogens [181, 182]. Some reported that smoking has little effect on the subgingival
microflora [183-187].
At the same time, studies have suggested that smokers harbor a greater number of
periodontal pathogens than non-smokers [188-191]. Recent studies, using real-time PCR,
have demonstrated a positive relationship between the degree of smoking and amount of
bacteria and probing depth [192, 193]. In these investigations, the subgingival microbiome
of smokers was examined by traditional methods such as culturing, and targeted DNAbased assays such as polymerase chain reaction (PCR), real-time PCR, and DNA–DNA
hybridization.
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Owing differences in the experimental design and interpretation of the results, there might
be variations in the results. Microbiological studies showed that smokers had a higher
prevalence of bacterial species related to periodontal disease compared to nonsmokers,
including P. gingivalis, Aggregatibacter actinomycetencomitans, Bacteroides forsythus,
Prevotella intermedia, and Fusobacterium nucleatum. Data from the large Erie County
study

showed

that

the

proportions

of

subjects

positive

for Aggregatibacter

actinomycetamcomitans [194], P. gingivalis, and Tannerella forsythia [195] were higher
among smokers. The oral biofilm in smokers is distinct from that of nonsmokers by less
diversity [62].The flora of smokers contains fewer aerobic and anaerobic organisms with
interfering activity against bacterial pathogens, and harbors more potential pathogens.
Smoking cessation can lead to a decrease in the prevalence or proportion of many
periodontal pathogens, including Porphyromonas endodontalis, Dialister pneumosintes,
Parvimonas micra, F. alocis and T. denticola [196]. Increased prevalence of the keystone
pathogen P. gingivalis, has repeatedly been shown and infection is more persistent in
smokers compared with non-smokers [197]. The adoption of 16S ribosomal RNA gene
(rDNA) amplification by PCR, followed by cloning and sequencing, has allowed more
comprehensive broad-range investigation of oral bacterial communities. This method
allowed for the identification of many un-culturable unknown species in subgingival biofilm
[198, 199]. These studies identified that the microbial profile of smokers with periodontitis
is distinct from that of non-smokers and predominated by periodontal pathogens [158,
198, 200].
1.9.c. Cigarette smoke and P. gingivalis:
It is assumed that the oral cavities of smokers, including the oral tissues and their
microbiota, are exposed to high concentrations of nicotine and cotinine [201]. Nicotine and
cotinine concentrations are much higher in saliva and gingival crevicular fluid than in
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plasma [202]. Nicotine is the abundant alkaloid and cotinine is the primary metabolite of
nicotine. In vitro and in vivo studies have demonstrated that nicotine can affect various
functions of human periodontal ligament fibroblasts, upregulate the lipopolysaccharidemediated secretion of prostaglandin E2 by monocytes, stimulate osteoclast resorption,
augment cytokine levels in nicotine-treated mice and have other deleterious effects on the
periodontal

tissues

[203-208].

Sayers et al.

reported

a

synergic

interaction

between P. gingivalis toxins and nicotine or cotinine. The colonization of epithelial cells
by P. gingivalis may also be altered in the presence of nicotine or cotinine [172, 209].
Nicotine and cotinine, have been shown to increase the lethality of cell-free extracellular
toxins and cell lysates from P. gingivalis in a chick embryo model [210, 211]. The
combination

of

benzopyrene,

a

tobacco

smoke

aryl

hydrocarbon,

and P.

gingivalis lipopolysaccharide (LPS) significantly increase the inhibition of osteogenesis in
a rat bone marrow cell model compared to either agonist alone [212]. In an in vitro model,
periodontal ligament (PDL) cells treated with both nicotine and LPS increased the
expression of MMP-1, MMP-2, MMP-3, PGE2, cyclooxygenase-2 (COX-2) and tissue-type
plasminogen activators in osteoblasts [213, 214]. It also stimulates the formation of
osteoclast-like

cells

by

increasing

macrophage

colony-stimulating

factor

and

PGE2 production in osteoblasts [215]. Nicotine and LPS synergistically induced the
production of nitric oxide and PGE2, and increased the expression of inducible nitric oxide
synthase (iNOS) and COX-2 via heme oxygenase-1 in PDLCs [216]. From these studies,
it is evident that the pro-inflammatory potential of P. gingivalis is reduced in the presence
of nicotine. This synergy, between nicotine and P. gingivalis LPS, results in deregulation
of several host immune responses which work to combat the invading bacteria, thus
promoting the growth of other pathogenic bacteria.
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Other studies explain the increased infection in smokers due to modification of host
immunity, but few studies explain the influence of tobacco smoke on the agent factors
(oral bacteria). Host and environmental stimuli may confer a selective growth advantage
to pathogenic organisms. Bacterial adaptation to these environmental conditions might be
the cause for the persistent bacterial infection in smokers [69].
Virulence of periodontal pathogens may vary as a result of differed gene expression of
virulence factors specific to particular environmental conditions [69, 217]. In a study done
by Bagaitkar et al., it was shown that CSE (cigarette smoke extract) significantly influences
the expression of 6.8% of the P. gingivalis genome, as determined by microarray analysis.
This included genes regulating capsule and fimbriae, oxidative stress and, DNA repair.
Regulation in response to CSE of fimA and capsule was further confirmed by an in vitro
study, where there was a significant increase in homotypic biofilm formation in the
presence of CSE [218].
P. gingivalis adapts to the environmental stress induced by CSE by altering the expression
of several genes and outer membrane proteins [180]. To withstand these adverse effects,
there might be upregulation of certain genes for the repair of damaged organelles. Despite
information regarding various virulence factors of P. gingivalis and their host interactions
at the phenotypic level, the genes essential for the survival of P. gigngivalis in smokers
have not been identified.
1.10. Periodontal diseases and GDM:
Pregnancy is associated with the development of new periodontal disease and
progression of periodontitis [219, 220]. The prevalence of gingivitis in pregnant women
has reportedly ranged from 30% to 100% [220]. Globally, 40% to 60% of females
experience gingivitis during their pregnancy [221]. The severity of pregnancy-related
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gingivitis usually increases in the second trimester. Periodontal diseases are associated
with pre-term labor and congenital disabilities [222]. GDM also has been associated with
poor pregnancy outcomes including preeclampsia, cesarean delivery, premature rupture
of membranes, and preterm delivery [223-226]. GDM is defined as any degree of glucose
intolerance with an onset first recognized during pregnancy [227]. As per a Center for
Disease Control and Prevention (CDC) report, the prevalence of GDM in the United States
may be as high as 9.2%. The International Diabetes Federation (IDF), Diabetes Atlas
2015, estimates that one in seven births is affected by GDM. Women with gestational
diabetes had a greater risk of developing more severe periodontal disease during
pregnancy than those without [228, 229]. It has been shown that poor glycemic control
results in increased subgingival infection with P. gingivalis and T. denticola [230]. Studies
have indicated that treating periodontal disease in pregnancy can reduce the likelihood of
pre-term birth. Others have found no such reduction for births at less than 37 weeks of
gestation, but have suggested evidence of a benefit for births before 32 weeks [231-234].
Inflammatory mediators that occur in periodontal disease play a significant role in the
initiation of labor [235]. Increased levels of C-reactive protein, TNF-α, and IL-6 among
women with gestational diabetes mellitus suggest a role of infection and inflammation in
its etiology [236-238]. In a study by Dasanayake et al., women with gestational diabetes
mellitus had levels of C-reactive protein significantly higher than those without. During
pregnancy, accumulation of hormones in gingival tissues affects gingival vasculature, and
the local immune system reaction to dental plaque [239].The increased level
of progesterone during pregnancy may provide a favorable environment for certain
gingivitis-causing bacteria. These increased levels of progesterone may also make gum
tissue more sensitive to plaque, exaggerating the host response. Mittas et al. found that
plaque accumulation during GDM might be the main reason for gingival inflammation.
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Periodontal diseases may increase the systemic inflammatory challenge, due to
hematogenous spread of bacteria and their products as a result of ulceration of epithelial
cells in periodontal pockets [240, 241]. P. gingivalis and T. denticola were found at a
significantly higher level among the pregnant women with periodontitis [221]. Recent
metagenomic analysis studies revealed that placental microbiome profiles were similar to
the oral microbiome [242]. P. gingivalis has been found in the amniotic fluid in addition to
the subgingival plaque and [222]. P. gingivalis was detected in the placentas of pregnant
women with periodontitis who had preterm deliveries [241]. There was exacerbated
gingival inflammation in an animal model when pregnant mice were challenged with P.
gingivalis [243]. In an animal model, P. gingivalis-derived LPS infected pregnant mice
exhibited reduced fetal weight and increased fetal resorption [244]. Another periodontal
pathogen, T. denticola has also been associated with pregnancy complications and poor
pregnancy outcome [221, 222, 243, 245]. In a mouse model, it has been shown that T.
denticola has an ability to disseminate to distant sites from the site of infection [246]. In a
mouse subcutaneous model, it has been shown that the newly emerging periodontal
pathogen, F. alocis has the ability to colonize and spread to distant sites [54].
There are many studies showing the relationship between periodontitis, GDM and poor
pregnancy outcomes; periodontal diseases, GDM and oral pathogens; and the
interrelationship between periodontitis and GDM. There are few studies that addressed:
the relationship between pregnancy-associated gingivitis and oral pathogens; and GDM
and oral pathogens. Numerous studies show that gingivitis in pregnant women can occur
due to physiological condition rather than the accumulation of plaque. In chapter 2 we
studied whether there exists any relationship between pregnancy gingivitis; GDM and the
established periodontal pathogens, P. gingivalis, T. denticola and F. alocis.
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CHAPTER 2
INCREASED INFECTION WITH KEY PERIODONTAL PATHOGENS DURING
GESTATIONAL DIABETES MELLITUS
2.1. Introduction
Increased gingival inflammation is well documented during pregnancy [247-249], and
periodontal diseases increase the risk for maternal (hypertension and preeclampsia) and
fetal complications (low birth weight and pre-term birth) [250-256]. For example, active
periodontal inflammation, as determined by bleeding on probing, has been reported to
correlate with reductions in fetal femur length, birth weight and birth length [253]. Indeed,
it has even been suggested that periodontal disease severity may predict adverse
pregnancy outcome [257].
Gestational diabetes mellitus (GDM) occurs in 2 to more than 10% of pregnancies [258]
and also increases the risk for pregnancy complications, such as placental abnormalities,
pre-eclampsia, emergency cesarean delivery, and stillbirth, as well as future development
of type 2 diabetes mellitus [259-263].
Diabetes and periodontal inflammation correlate, with overt diabetes associated with an
increased risk of more severe periodontitis while periodontitis has been associated with
worsened glycemic control in subjects with diabetes [264-267]. There are only a few
studies that address the interrelationships of GDM and gingivitis during pregnancy,
specifically, and exacerbation of gingival inflammation by gestational GDM [228, 268,
269].
Gingivitis is a bacterial-induced disease and specific dental plaque pathogens,
including P. gingivalis and Treponema denticola, have been associated with poor
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pregnancy outcomes [221, 222, 240, 243, 245]. Furthermore, poor glycemic control has
been reported to result in increased subgingival infection with these same two pathogens
[230]. Increased low-grade systemic inflammation has been suggested to be related to
pregnancy complications, such as preeclampsia [54, 270], with elevated levels of the
acute phase protein, C-reactive protein (CRP), suggested to be an effective early
biomarker for GDM [271].
We hypothesized that both pregnancy-associated gingivitis and gestational diabetes
mellitus would be associated with increased oral infection with key oral pathogens and we
set out to monitor oral infection with P. gingivalis, T. denticola, and the recently emergent
oral pathogen, Filifactor alocis [29], as well as the systemic inflammatory burden, in 117
pregnant women with and without gingivitis and with and without gestational diabetes.
2.2. Materials and Methods
Materials
Chelex 100 was purchased from Bio-Rad Laboratories (Hercules, CA, USA), PCR primers
came from Bio-Synthesis Inc. (Lewisville, TX, USA), while PCR SuperMix and UltraPure
distilled water were from (Invitrogen, Carlsbad, CA, USA). Gifu anaerobic medium (GAM)
was purchased from Nissui Pharmaceutical (Tokyo, Japan) while brain heart infusion
(BHI) medium came from Becton Dickenson (Sparks, MD, USA). Fetal bovine serum was
obtained from Atlanta Biologicals (Lawrenceville, GA, USA). All other media components
came from Sigma-Aldrich (St. Louis, MO, USA). High sensitivity cotinine immunoassays
were obtained from Salimetrics (State College, PA, USA). Finally, CRP EIA kits were
ordered from Cayman Chemical Company (Ann Arbor, MI, USA).
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Study population
All individuals were recruited between September 2012 and March 2013 at the
Endocrinology and Metabolism outpatient clinic, Aydın State Hospital, Aydın, Turkey. The
study was conducted in full accordance with ethical principles, including the World Medical
Association's Declaration of Helsinki, as revised in 2008. The protocol was approved by
the Ethics Committee of Medical Faculty of Ege University (protocol number 13-2/9). The
study protocol was explained and written informed consent was received from each
individual before enrollment in the study. Medical and dental histories were obtained from
each individual, and saliva and serum samples were obtained before the clinical
periodontal examination. The inclusion criteria were being in the third trimester, and having
no other diagnosed systemic diseases requiring usage of medications such as antibiotics,
non-steroidal anti-inflammatory drugs, corticosteroids or drugs that cause gingival
overgrowth. Smoking status was determined according to the self-reports of the pregnant
women and then verified biochemically by salivary cotinine analysis. The exclusion
criterion was a body mass index (BMI) value ≥30 (kg/m2).
Gestational diabetes mellitus was diagnosed according to the current American Diabetes
Association criteria [272], i.e. a 75 g oral glucose tolerance test was administered, with
fasting plasma glucose measurement at 1 and 2 h, at 24–28 weeks of gestation in women
not previously diagnosed with overt diabetes. GDM was diagnosed if the following
threshold values were met: fasting, ≥92 mg/dl (5.1 mmol/l); 1 h, ≥180 mg/dl (10.0 mmol/l);
and 2 h, ≥153 mg/dl (8.5 mmol/l).
Gingivitis was diagnosed as previously described [273-275], i.e., when bleeding on
probing (BOP) was present at >50% of all sites and probing depth (PD) was <3 mm at
≥90% of the measured sites, no more than one site with a PD >4 mm and clinical
attachment level (CAL) ≤1 mm. All participants had ≥20 teeth present. Periodontally
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healthy women were required to present with <30% BOP, and no clinical sign of alveolar
bone loss. Plaque index (PI) was recorded as present or absent following visual
examination [276].
Saliva and serum sampling
Whole, unstimulated saliva samples were obtained, before any clinical measurement or
periodontal intervention, by expectoration into polypropylene tubes in the morning,
following an overnight fast, during which participants were requested not to drink (except
water) or chew gum, essentially as previously reported [277]. The saliva samples were
clarified by centrifugation (800 g) for 10 min at room temperature, and 500 μl amounts
were placed in polypropylene tubes, and immediately lyophilized Venous blood (5 ml) was
taken from the antecubital vein by standard venipuncture. Serum was separated by
centrifugation at 1500 g for 10 min and immediately frozen at −40°C then lyophilized.
Samples were shipped to the University of Louisville for biochemical and microbiological
analysis. Ethical approval to analyze biomedical samples originating in Turkey was
obtained from the Institutional Research Board of the University of Louisville (protocol
number 13.0670).
Determination of systemic CRP concentrations
Circulating CRP was measured in serum using EIA kits, according to the manufacturer's
instructions (Cayman Chemical Co.), using an Emax Precision Microplate Reader
(Molecular Devices, Sunnyvale, CA, USA). The reported sensitivity of the assay is
50 pg/ml.
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Determination of salivary cotinine concentrations
Salivary cotinine was measured using a high sensitivity cotinine immunoassay
(Salimetrics) and an Emax Precision Microplate Reader, as previously reported [277]. The
reported sensitivity of the assay is 0.15 ng/ml.
Growth of periodontal pathogens
P. gingivalis ATCC 33277; F. alocis ATCC 38596; and T. denticola ATCC 35405 were
grown to mid-to-late log phase at 37°C (80% N2, 10% H2, 10% CO2) in GAM; BHI
supplemented with FBS (5%), L-cysteine (0.1%) and arginine (20%); and new oral
spirochete broth (with veal heart infusion replaced with BHI and KH2PO4 omitted) [278],
respectively, in an anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA).
Detection of pathogens
The presence or absence of bacterial DNA was determined by four PCR amplifications
per Chelex 100 (25% mass/volume)-treated saliva sample, using primers documented in
Table 1. Cycling parameters were as previously reported [277, 279, 280]. DNA extracted
from cultured periodontopathogens and water served as positive and negative controls,
respectively. P. gingivalis, T. denticola, F. alocis and universal 16S rRNA amplicons were
visualized using the Lonza Flashgel system (Rockland, ME, USA).
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Table 1: Primers used to detect bacterial DNA in saliva

Data analyses
The sample size was based on precedent literature examining the relationships between
diabetes, pregnancy, CRP concentrations and infection with oral pathogens [229, 230,
240, 271, 281]. Statistical significance was determined using Instat v3.06 (GraphPad,
San Diego, CA, USA). Parametric or nonparametric ANOVA with Tukey or Dunn posttesting, respectively, and Fisher's Exact Test were employed, as appropriate.
Correlations between measurements of interest were determined by Spearman rank
analysis. Significance was set at p ≤ 0.05.
2.3. Results
The characteristics of all recruited women are shown in Table 2. The periodontally healthy
group with GDM was older than the periodontally healthy group without GDM by an
average of 3.4 years. As expected, all clinical parameters were higher in those with
gingivitis compared to the periodontally healthy women while those with GDM had a higher
BMI than those who did not. By chance, the groups were matched for smoking (smoking
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yes versus no). Furthermore, there was no correlation between cotinine concentration and
BoP (p = 0.636), perhaps due to the small number of smokers and low cotinine
concentrations.

Table 2: Characteristics of the study population
Women

with

gingivitis

during

pregnancy

periodontopathogens
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are

more

likely

to

harbor

As expected, because gingivitis is a bacteria-induced disease, pregnant subjects with
gingivitis were more likely to harbor periodontopathogens than those who were
periodontally healthy, as shown in Table 3.

Table 3: Infection with periodontal pathogens.
Women

with

gestational

diabetes

mellitus

are

more

likely

to

harbor

periodontopathogens
Gestational

diabetes

mellitus

itself

was

associated

with

increased

infection

with P. gingivalis, F. alocis, T. denticola, or a multiplicity of infection of individuals both
with and without gingivitis, as shown in Table 3.
Gingivitis dramatically elevates systemic CRP in pregnant women
The systemic inflammatory burden, as determined by CRP measurement, was higher in
those with gingivitis only compared to those without gingivitis (with or without GDM,
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both p < 0.01) but not those with gingivitis and GDM, as shown in Figure 1. The mean
(SD) CRP concentrations for those without gingivitis or GDM, with gingivitis only, with
GDM only and those with both gingivitis and GDM, was 2495 (3007); 8386 (10006); 1838
(1389); and 8698 (4938) ng/ml, respectively. There was no correlation between cotinine
concentration and CRP (p = 0.835), again perhaps due to the small number of smokers
and low cotinine concentrations. Similarly, there was no correlation between BMI and CRP
(p = 0.265) for the total population, likely reflecting the importance of gingival
inflammation.

Figure 1: Systemic Inflammation (CRP) is elevated in pregnant women with
gingivitis. The systemic CRP burden in women with and without gingivitis and
with and without GDM are presented. The line and error bars represent mean (SD)
values. **p≤0.001.
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2.4. Discussion
A recent systematic review of the available epidemiological evidence determined that
maternal periodontitis is independently associated with adverse pregnancy outcome, but
that interpretation of the data is impacted by disease definition [282], a conclusion
supported by a recent study [283]. Increased bacterial infection and systemic inflammation
related to moderate and severe periodontitis are each risk factors for poor pregnancy
outcome [248, 284, 285]. Specific microbial signatures of the subgingival biofilm were able
to distinguish between microbiomes of periodontal health, gingivitis and periodontitis and
these profiles may be helpful in establishing the risk of disease [286]. Herein, we
specifically address the interactions of a different type of periodontal disease, gingivitis,
and GDM.
Infection with periodontal bacteria has been reported to be an important indicator of poor
pregnancy outcome, particularly pre-term and/or low birth weight infants [240, 287-290].
P. gingivalis is an anaerobic, Gram-negative bacterium and a causative agent of chronic
periodontitis that is associated with several systemic sequelae, including pregnancy
complications [222]. Even at low colonization levels, P. gingivalis employs a variety of
strategies to control the commensal microbiota and direct disease progression and is thus
regarded as a keystone species [19]. T. denticola, a highly motile, invasive, Gramnegative anaerobe, is also a causative agent of periodontitis that has been associated
with pregnancy complications [245]. F. alocis is an anaerobic, Gram-positive bacterium,
that has recently been identified by human microbiome projects as a pathogen associated
with chronic periodontitis, aggressive periodontitis and endodontic lesions [56]. The
potential relationship between F. alocis and maternal or fetal health, to the best of our
knowledge, has not been examined.
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From a mechanistic perspective, P. gingivalis has been the most extensively studied oral
microbe. For example, injection of anti-P. gingivalis antibodies that are cross-reactive with
cardiolipin into the tails of pregnant mice have been shown to increase fetal loss, relative
to control antibody [291]. Administration of P. gingivalis-derived LPS to mice reduces fetal
weight and increases fetal resorption [244]. Furthermore, P. gingivalis DNA has been
found in chorionic tissues of high-risk pregnant women [292] and in the amniotic fluid of
women bearing pre-term and/or low birth weight infants [240].
Saliva collection is more convenient, and thus likely to facilitate more ready recruitment
than the isolation of subgingival dental plaque samples, while there are multiple reports
that subgingival bacteria can be readily monitored in saliva and, furthermore, that bacteria
detected in saliva correlate with periodontal disease status [293-295]. Therefore, saliva,
rather than plaque, was employed herein. A high rate of infection with the emerging
pathogen, F. alocis

(48.1–76.3%)

and

the

established

but

understudied

pathogen, T. denticola (61.3–86.8%) was observed in all subject groupings. Despite this
high background, gingivitis during pregnancy increased infection with periodontal
pathogens in women with and without GDM. In those without GDM, gingivitis was
associated with an increased frequency of detection of DNA from P. gingivalis, F. alocis,
and combinations of the three targeted bacteria. In those with GDM, gingival inflammation
resulted in increased infection with P. gingivalis, T. denticola, and combinations of the
three targeted bacteria.
GDM itself increased the likelihood of infection with periodontopathogens in those with
and without gingivitis during pregnancy. In those without gingivitis, GDM was associated
with an increased frequency of detection of DNA from F. alocis and combinations of the
three targeted bacteria. In those with gingivitis, GDM was associated with increased
infection with P. gingivalis, T. denticola, and combinations of the three targeted bacteria.
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Thus,

gingivitis

and

GDM

each

increase

the

incidence

of

infection

with

periodontopathogens, an established risk factor for pregnancy complications.
Increased systemic inflammation has been suggested to be related to pregnancy
complications, such as preeclampsia [54, 270], with elevated levels of the acute phase
protein, C-reactive protein (CRP), reported to be an effective early biomarker for GDM
[271]. All women were recruited during the third semester, the stage of pregnancy when
CRP levels have been reported to be highest in those with GDM [237]. In women with
periodontitis and pre-eclampsia, [296] it was found that CRP levels reflected periodontal
disease severity. Here, we establish that CRP, employed as a biomarker of systemic
inflammation, is dramatically elevated in women with gingivitis during pregnancy,
irrespective of GDM diagnosis. CRP concentration is hypothesized to be related to fat
deposition and BMI only in early pregnancy, with impaired glucose metabolism important
only later in gestation [237, 297, 298]. Therefore, it is important to note that enrolled
women with GDM had significantly higher mean BMI than those without GDM. In baboons,
[299] have reported that immunoglobulin responses to oral bacteria (Fusobacterium
nucleatum, P. gingivalis, Aggregatibacter actinomycetemcomitans and

Campylobacter

rectus) were associated with systemic inflammation during ligature-induced periodontitis
in pregnancy [299].
It will be important to confirm these results in a larger population to ensure that the sample
size (four groups of 21–38 subjects each) has not affected results such as CRP-BMI or
smoking-CRP associations. In conclusion, and considering this limitation, these data
suggest a bidirectional relationship between GDM and gingivitis, although, it has yet to be
established if this concerted influence results in poor pregnancy outcome per se.
Nevertheless, GDM and gingivitis are each associated with increased infection from
pathogenic oral bacteria, while gingivitis increases systemic inflammation, irrespective of
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GDM. The present study focuses on microbiological data and CRP level with regard to
GDM and gingivitis. Further biochemical analysis of cytokine and collagenase levels are
planned in the same study population.
Unfortunately, while intensive oral hygiene can be effective in decreasing gingivitis
during pregnancy [300], women appear to receive less than their normal dental care
when pregnant [301]. If confirmed, these results suggest that increased efforts to control
gingivitis and glycemic control during pregnancy may help to reduce two important risk
factors for poor pregnancy outcomes.
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CHAPTER 3
COMPARISON OF INHERENTLY ESSENTIAL GENES OF PORPHYROMONAS
GINGIVALIS IDENTIFIED IN TWO TRANSPOSON-SEQUENCING LIBRARIES
3.1. Introduction
Periodontitis, a microbially-driven, destructive disease of the tissues surrounding the teeth
occurs in approximately 50% of the population [302]. Increasing evidence suggests that
periodontitis is associated with elevated risk of vascular diseases, including coronary
artery disease and stroke, diabetes mellitus, lung diseases such as chronic obstructive
pulmonary disease and pneumonia, rheumatoid arthritis, preterm low birth weight delivery,
and even some forms of cancer [303-307].
The anaerobic, Gram-negative bacterium P. gingivalis is an emerging systemic pathogen
and a causative agent of chronic periodontitis. P. gingivalis has been proposed as the
prototypic oral keystone pathogen [17], that is, a bacterium that promotes dysbiosis and
inflammation-driven tissue destruction even at low levels of infection. P. gingivalis ATCC
33277 is one of the most commonly employed strains in periodontal research and is
pathogenic in experimental animals following oral infection [137]. The P. gingivalis ATCC
33277 genome is comprised of 2155 genes, 2090 of which encode proteins, and there are
no plasmids [32, 147, 148]. Recently, Klein et al [148] generated a Mariner transposon
insertion mutant (TnSeq) library (which we denote Library 1) for this P. gingivalis strain
and used it to identify 463 genes potentially required for in vitro viability. We have
independently generated a TnSeq mutant library for P. gingivalis ATCC 33277 (Library 2),
building on our previous work on Vibrio and Pseudomonas gene fitness [308-310].
There is no fully defined medium for P. gingivalis, and different complex media are likely
to provide different nutritional environments. Therefore, we hypothesized that multiple
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genes essential for planktonic growth in complex media would be common (i.e. potentially
representing the core genome) and divergent (i.e. environment-specific) between Library
1 and Library 2.
3.2. Materials and Methods
Materials
P. gingivalis ATCC 33277 was cultured in Gifu anaerobe medium (GAM; Nissui
Pharmaceutical, Tokyo, Japan) and on GAM blood agar. Escherichia coli DH5α and
pSAM_Bt were cultured in Luria–Bertani broth and agar from BD Biosciences (San Jose,
CA). Sheep blood was from Lampire Biological Laboratories (Pipersville, PA). Gentamicin,
erythromycin, ampicillin, dichloromethane, sodium sulfate and analytical nicotine
standards were from Sigma-Aldrich (St. Louis, MO). GeneReleaser® came from Bio
Ventures, Inc. (Murfreesboro, TN). All primers were from Biosynthesis Inc. (Lewiston, TX).
Lonza flash gels came from Lonza (Rockland, ME). Wizard SV and PCR clean-up kit were
from Promega (Madison, WI). T4 DNA Ligase and buffer; MmeI; and TAE buffer came
from New England Biolabs (Ipswich, MA), while HiFi Hotstart Readymix was from KAPA
Biosystems (Wilmington, MA) and the polymerase chain reaction (PCR) SuperMix came
from Invitrogen (Carlsbad, CA).
Generation and validation of a P. gingivalis ATCC 33277 transposon sequencing
library
An ATCC 33277 mariner transposon insertion library was generated. P. gingivalis was
inoculated into GAM without antibiotics; E. coli strain DH5α containing the pSAM_Bt
plasmid was grown in Luria–Bertani broth with ampicillin; and a 5:1 ratio of log
phase P. gingivalis to E. coli was employed for conjugation. pSAM_Bt was originally
employed to generate the first TnSeq library in the
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porphyromonad-related

microbe, Bacteroides

thetaiotaomicron [311].

Gentamicin

(E. coli is

sensitive; P. gingivalis is naturally resistant) and erythromycin (resistance is transposonencoded) were used to select for insertion mutants grown on GAM/blood agar plates.
Random insertion in the P. gingivalis genome was confirmed by nested semi-random
PCR. One hundred randomly selected colonies were harvested to test for hot spots of
insertion of the transposon by semi-nested PCR involving two rounds of PCR. DNA was
harvested from selected colonies by GeneReleaser® following the manufacturer's
protocol. Round one PCR was performed with Invitrogen Supermix using Round 1-pSAM
and Round 1-RndomPG primers (Table 7) under the following conditions: 94°C for 3 min;
94°C for 30 s, 50°C for 40 s, 72°C for 3 min, 10 cycles; 94°C for 30 s, 62°C for 40 s, 72°C
for 3 min, 25 cycles. Round one PCR products were used for round two PCR amplification
using Round 2-PG and Round 2-pSAM primers (Table 7) under the following conditions:
94°C for 3 min; 94°C for 30 s, 57°C for 40 s, 72°C for 3 min, 30 cycles; 72°C for 5 min.
Amplicons were run on a Lonza flash gel system to verify correct fragment size. 16S rRNA
gene-specific primers (Table 7) were also used to confirm P. gingivalis specificity with the
same cycle conditions as round 2 of the nested PCRs employed.
Identification of essential genes for planktonic growth in GAM
The mutant library was passaged twice after the culture reached mid-late log phase in
1 liter of GAM broth containing gentamicin (50 μg ml−1) and erythromycin (5 μg ml−1).
Genomic DNA from the mutant library (100 μg) was harvested using the Wizard DNA
isolation kit and digested with MmeI (1 h at 37°C; 20 min at 80°C). The DNA digest was
run on a 1% agarose gel and the band corresponding to the transposon plus the flanking
sequences (~1500) was extracted using a Wizard gel extraction kit, as per the
manufacturer's instructions. A double-stranded DNA adapter was created using the
primers LIB_AdaptT_4 and LIB_AdaptB_4 (Table 7). The primers were combined and
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heated at 95°C for 5 min and then allowed to cool to room temperature. The dsDNA
adapter was ligated to the gel purified DNA product using T4 DNA ligase (16 h at 16°C;
10 min at 65°C). Ligation products purified by a Wizard purification kit and amplified by
PCR using HiFi Hotstart SuperMix with LIB_PCR_5 and LIB_PCR_3 primers (Table S1)
under the following conditions: 98°C for 3 min; 98°C for 20 s; 60°C for 1 min; 72°C for
1 min, 18 cycles; 72°C for 4 min. The PCR product was purified using a Wizard purification
kit and run on a Lonza flash gel system to verify the 125-base-pair band. Products were
quantified using a NanoDrop ND-1000 spectrophotometer (Wilmington, DE) and
sequenced at the University of Michigan DNA Core. The sequences were read by 50base-pair single end reads. The prepared mutant library DNA was run on a single flow cell
lane on the Illumina HiSeq2000 platform. The resulting reads were analyzed by
CLC Genomics Workbench 7.1.1. Adapter sequences were removed along with the
sequence corresponding to the end of the transposon. All sequences with reads with a
quality score <0.05 or of <15 nucleotides were removed. The remaining reads were
aligned to the annotated gene list of P. gingivalis strain ATCC 33277. To control for
variations in gene length and depth of coverage, normalized genes with <0.5 reads per
kilobase per million (RPKM) mapped reads were considered essential. The remaining
genes were determined to be non-essential for survival in GAM broth.
Cross library comparison of essential genes for planktonic growth in complex
media
The genes essential for survival in GAM broth were compared with the previously
published list of essential genes for survival in supplemented brain–heart infusion broth
[148]. The function and interrelationships of the 281 common inherently essential genes
for planktonic growth of P. gingivalis in complex media were investigated in silico by
KEGG (www.genome.jp/kegg) database analyses. The common essential genes were
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mapped

to

the P. gingivalis ATCC

33277

genome

using

CGViewer

(Stothard.afns.ualberta.ca/cgview_server/) [312] and compared with the Database of
Essential Genes (DEG; tubic.tju.edu.cn/deg/, blastx search, <1e-8) [313].
3.3. Results
Random insertion in the P. gingivalis ATCC 33277 genome, which contains ~117,000 TA
sites distributed among 2155 genes, was confirmed by nested semi-random PCR, as
shown in Figure 2. Inherently essential genes common to Library 1 and Library 2 were
mapped to the P. gingivalis ATCC 33277 genome using CGViewer, as presented in
Figure 3. KEGG analysis (www.genome.jp/kegg) was employed to functionally classify the
same P. gingivalis gene set, as noted in Table 4. The highest percentage of essential
genes found within the functional groupings was for those whose products are involved in
protein export, 89% of which were essential under these conditions. Similar functional
groupings were obtained using the DAVID database (https://david.ncifcrf.gov). Functional
relationships between the common essential genes were determined, using KEGG, as
shown in Fig. 4a–e. Finally, the complete database of 281 common genes is provided in
Table 5. These have been entered into the Database of Essential Genes [313].
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Figure 2: Validation of TnSeq library. (A) 16S rDNA confirmation of P. gingivalis;
expected band size of 463 bp(B) random insertion determined by nested
polymerase chain reaction (lanes from 100 randomly selected colonies).
Approximately 80,000 insertion strains (individual mutants) were generated in the
ATCC 33277 chromosome.

42

Figure 3: Map of putative common inherently essential genes for the planktonic
growth of P. gingivalis in complex media. Common essential genes were mapped
to the P. gingivalis ATCC 33277 genome using CG viewer (Grant& Stothard,2008).
The blue arrows show the location of the 281-putative common essential genes
within the P. gingivalis 33277 chromosome. The adjacent two rings depict gene
orientation (outer and inner blue arrows represent the positive and negative
strands, respectively). The next two rings represent the coding sequences for P.
gingivalis TDC60 and W83 strains, respectively.
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Table 4: Functional classification of inherently essential genes of P. gingivalis
common to two transposon sequencing libraries based on the KEGG analysis.
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Figure 4a. Pyrimidine Metabolism (pathway enriched among inherently essential
P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are presented with
the proteins catalyzing each step shown by their enzyme commission number and
substrates/products. Green shading indicates the presence of homologs in P.
gingivalis. The red star denotes essential genes. The PGN assignments of the
essential metabolic genes are provided in Table 9.
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Figure 4b. Lipopolysaccharide Biosynthesis (pathway enriched among inherently
essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 9.
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Figure 4c. Peptidoglycan Biosynthesis (pathway enriched among inherently
essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 9.
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Figure 4d. Pantothenate and CoA Biosynthesis (pathway enriched among
inherently essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg)
are presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 9.
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Figure 4e. Nicotinate and Nicotinamide Metabolism (pathway enriched among
inherently essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg)
are presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 9.
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Table 5: Inherently essential genes of P. gingivalis identified in two transposon
sequencing libraries (n= 281).
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Media

Composition

Supplemented

Brain-heart infusion (unspecified concentration), yeast

brain-heart infusion

extract (1 mg/ml), hemin (5 µg/ml), menadione (0.5 µg/ml),

broth

sodium bicarbonate (1 mg/ml), sodium thioglycolate (0.25

(BHIHKSbcStgC)

mg/ml), cysteine (0.5 mg/ml). Gentamicin (25-50 mg/ml)

Library 1 (Klein et al.

and erythromycin (2-10 mg/ml) also employed.

2012)

Gifu Anaerobe

Peptic digest of animal tissue (10 mg/ml), papaic digest of

Media (GAM)

soyabean meal (3 mg/ml), proteose peptone (10 mg/ml),

Library 2 (herein)

digested serum (13.5 mg/ml), yeast extract (5 mg/ml),
beef extract (2.2 mg/ml), liver extract (1.2 mg/ml),
dextrose (3 mg/ml), H2KO4P (2.5 mg/ml), NaCl (3 mg/ml),
soluble starch (5 mg/ml), L-cysteine hydrochloride (0.3
mg/ml), and sodium thioglycolate (0.3 mg/ml). Gentamycin
(50 µg/ml) and erythromycin (5 µg/ml) also employed.

Table 6: Composition of (A) BHIHKSbcStgC and (B) GAM complex media
employed for the growth of P. gingivalis ATCC 33277.
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ID

Sequence(5’ -> 3’)

Pg16S-F

AGG CAG CTT GCC ATA CTG CG

Pg16S-R

ACT GTT AGC AAC TAC CGA TGT

LIB_PCR_5

CAA GCA GAA GAC GGC ATA CGA AGA CCG GGG
ACT TAT CAT CCA ACC TGT

LIB_PCR_3

AAT GAT ACG GCG ACC ACC GAA CAC TCT TTC
CCT ACA CGA CGC TCT TCC GAT CT

Round 1RndomPG-1

GGC CAC GCG TCG ACT AGT AC NNNNNNNNNN
CGATG

Round 1RndomPG-2

GGC CAC GCG TCG ACT AGT AC NNNNNNNNNN
GGTAG

Round 1RndomPG-3

GGC CAC GCG TCG ACT AGT AC NNNNNNNNNN
CGAAG

Round 1RndomPG-4

GGC CAC GCG TCG ACT AGT AC NNNNNNNNNN
CAGCAG

Round 1RndomPG-5

GGC CAC GCG TCG ACT AGT AC NNNNNNNNND
CAGCAG

Round1-pSAM

TCG AGG GCG CGC CAA GCA G

Round2-PG

GGC CAC GCG TCG ACT AGT AC

Round2-pSAM

CGC GCC AAG CAG AAG ACG GCA TAC G

LIB_AdaptT_4

TTC CCT ACA CGA CGC TCT TCC GAT CTT TTC
CNN

LIB_AdaptB_4

GGA AAA GAT CGG AAG AGC GTC GTG TAG GGA A

Table 7: Sequence of primers employed throughout the study.
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Table 8: Pathways enriched among inherently essential P. gingivalis genes.
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3.4. Discussion
A comparison of two independently generated TnSeq libraries for P. gingivalis ATCC
33277 suggests that 281 common genes are essential for in vitro growth in two complex
media. This minimal P. gingivalis genome is rich in genes performing critical physiological
processes,

particularly

pyrimidine

metabolism

as

well

as

lipopolysaccharide,

peptidoglycan, and coenzyme A biosynthesis. Those genes that encode established
virulence factors, such as gingipains [101], fimbriae [314], capsule [105], and RagB [315],
are underrepresented in this overlapping gene set, probably because there is no immune
or competing microbial challenge to be met. In other words, they are likely to be
conditionally essential rather than inherently essential. Hence it could be reasoned that,
while targeting P. gingivalis components that drive pathogenesis in vivo is a valid
approach, the rather more mundane set of essential genes identified herein may prove to
be more efficacious in controlling P. gingivalis infections. It should be noted that the
‘essential’ gene set can change depending on the growth conditions. Some genes will
likely be required in all conditions (e.g. rpoN and lepB, identified herein) but the
importance of others will depend on the nutritional content of the medium, i.e. conditionally
essential genes. In the long-term, a comparison of inherently essential genes and genes
essential in multiple conditions will facilitate optimization of potential therapeutic targets.
In addition to the elucidation of genes grouped into metabolic pathways, there are other
essential genes that are interesting at the individual level. The rpoN gene (PGN_1202,
33277; PG1105, W83 orthologue; PGTDC60_1103, TDC60 orthologue), for example,
encodes the alternative sigma factor, σ54. Bacteroides spp. are rich in extracytoplasmic
sigma factors compared with other Bacteroidetes [316]. These sigma factors form part of
the RNA polymerase holoenzyme and control transcriptional specificity. σ54 is commonly
used for large-scale transcriptional changes by binding to different and more highly
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conserved consensus sequences than those for σ70 [317]. Furthermore, although there
are multiple members of the σ70 family – and the σ70 factor rpoD (PGN_0638; PG0594;
PGTDC60_1719) is also essential – there is only one member of σ54. Interestingly, rpoN is
not typically an essential gene in most systems. The only described instance
where rpoN has been shown to be essential in the soil bacterium, Myxococcus
xanthus [318]. Why the P. gingivalis rpoN gene is essential for in vitro growth remains to
be determined.
The heat-shock protein 60 homolog, groEL (PGN_1452; PG0520; PGTDC_1639), is an
emergent P. gingivalis virulence factor that has been proposed to promote cytokine
production and inflammation, to enhance osteoclastogenesis, to aid in the vascularization
of tumors and, perhaps, to play a role in atherosclerosis [319-322]. Although PGN_1452
is

not

itself

essential,

the groEL co-chaperone, groES (PGN_1451;

PG0520;

PGTDC60_1640) is required for growth in complex media. Another heat-shock protein
family member, dnaJ (PGN_1716; PG1776; PGTDC60_1360), and the gene encoding the
DnaK repressor (PGN_0516; PG1597; PGTDC60_0704) are further common essential
genes.
There are several proteolytic genes common to Library 1 and Library 2. These are genes
encoding: signal peptidase I (lepB; PGN_1946; PG1598; PGTDC60_0703); signal
peptidase II (lspA; PGN_0515; PG2001; PGTDC60_0274); as well as an aminoacylhistidine

dipeptidase

(PGN_0250;

PG0137;

PGTDC60_0414);

and

a

leucine

aminopeptidase (PGN_0202; PG2157; PGTDC60_1640) that is related to the M28 group
of metalloproteinases. P. gingivalis contains only a single copy each of lepB and lspA,
which are required for protein translocation across cell membranes, consistent with the
finding that these signal peptidases form part of the core genome. Additionally, the

55

majority

of

Sec-related

protein

export

genes

were

also

essential

(secY, secE, secG, secD/F, yajC, SecA, SRP54/ffh, and ftsY but not yidC).
Multiple genes that control bacterial shape, including those encoding RodA (PGN_0626;
PG703; PGTDC60_0579 and PGN_0870; PG1392; PGTDC60_2072), as well as MreB
(PGN_0866; PG1396; PGTDC60_2068), are also common inherently essential genes.
Interestingly, mreB is not usually an essential gene for most rod-shaped bacteria. Perhaps
the essentiality of mreB in P. gingivalis in laboratory media suggests a need to maintain a
rod shape to keep the surface area-to-volume ratio lower than that for a coccus.
Upon

interrogation

of

the

Database

of

Essential

Genes,

it

is

clear

that

some P. gingivalis ATCC 33277 genes have common essential homologs whereas others
are unique (n = 54; 19%) to this bacterium. Eighty-three (30%) genes have ≤10 essential
homologs, while 11 (n = 4%) have ≥50 homologs. Although it must be acknowledged that
the current database of known essential prokaryotic genes is limited to 36 bacterial
species other than P. gingivalis – because of the recent emergence of TnSeq technology
– the combination of common and unique required genes suggests that, in the long term,
it may be possible to generate both broad-spectrum and P. gingivalis-specific therapeutic
targets for the control of bacterial infections.
Differential phenotypes are sometimes reported for the same bacterial strains. Although
this can be partly explained, for example, by different model systems or the propagation
of relevant mutant genes within laboratory collections, the comparison of Library 1 and
Library

2

raises

another

possibility.

Despite

the

fact

that

both

libraries

are P. gingivalis ATCC 33277-specific, approximately half of the genes identified in
Library 1 were not common to Library 2. Considering that both libraries lack transposon
insertion hot spots and contain large mutant numbers (54,000 and 80,000 colonies,
respectively), the major difference between the experimental setups is the composition of
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the complex growth media employed (Table 6). As different nutritional and other needs
may be met by each of these complex media, this may be sufficient to induce considerable
differences in the adaptive response to such growth conditions, reflected in the different
profiles of essential genes. Performing similar analyses on other bacterial pathogens to
distinguish between inherently essential and conditionally essential genes may reveal
additional targets for new therapeutics.
In summary, we have identified 281 genes that are essential for in vitro survival of the
periodontal pathogen P. gingivalis as defined by two independently generated TnSeq
mutant libraries. It is expected, following validation of these genes by determining the
growth characteristics of essential gene deletion mutants and their complements, that
some of these required genes will represent novel therapeutic targets for the efficient
control of P. gingivalis.
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CHAPTER 4
IDENTIFICATION OF GENES ESSENTIAL FOR PORPHYROMONAS GINGIVALIS
SURVIVAL UNDER THE CONDITION OF CIGARETTE SMOKE INDUCED STRESS
4.1. Introduction
There are >1.3 billion smokers in the world (177). Smoking alone accounts for most cases
of periodontitis in adults in developed nations, like Scandinavia, New Zealand and the U.S.
[323-326]. Smokers exhibit reduced clinical signs of inflammation. In smokers, host- and
bacterial-derived tissue degrading proteinases enhance periodontal destruction [327-334].
Results of several cross-sectional and longitudinal studies showed smoking as a major
environmental risk factor associated with the development of extensive and severe
periodontal diseases [159, 198, 201, 335, 336]. Smoking results in periodontal destruction
in a dose-dependent manner [337, 338]. Probing pocket depths and tooth mobility scores
were highest among smokers having periodontitis [339, 340]. Oxygen tensions in
periodontal pockets are lower in smokers compared to non-smokers [171]. In smokers,
there is a chronic reduction of blood flow, altered neutrophil function, altered cytokine and
growth factor production, inhibition of fibroblast growth and attachment, decreased
collagen production and vascularity in the oral cavity, but increased levels of free radicals
and lipid peroxidation in periodontal tissues, and alteration in osteoclast activity [339, 341].
All these changes affect the pathogenesis of periodontal diseases and healing of the
periodontium after periodontal treatment in smokers. Thus, the local oral environment in
smokers is different from that of non-smokers. These changes in the oral environment
might exert selective pressure on the oral biofilms and in turn, lead to the selection of a
specific group of microorganisms.
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Many recent studies have established that cigarette smoke considerably affects
subgingival bacterial ecology. Smokers demonstrate a pathogen-rich, commensal-poor,
anaerobic, and dysbiotic oral microbiome, even in periodontally healthy individuals [342].
Despite the conflicting reports regarding the influence of smoking on the oral microbiome,
the microbial profile of smokers having periodontitis is distinct from that of non-smokers
[200, 342-344]. These studies suggest that there exists an association between smoking
and subgingival dysbiosis. Dysbiosis in smokers plays a significant role in the increased
severity of periodontitis [345].
In a study by Coretti et al., analysis of the putative biological functions of subgingival
microbial communities in smokers having periodontitis, non-smokers with periodontitis
and healthy individuals was performed [345]. In the microbiota of healthy subjects,
enzymes for biosynthesis and biodegradation of secondary metabolites, fatty acid
metabolism, and amino acid biosynthesis were upregulated. In smokers having
periodontitis, there was enrichment of genes encoding peptidases, enzymes for
lipopolysaccharide biosynthesis, and proteins involved in cell motility and secretions
compared to control subjects. Enrichment of such genes, suggests that there is enhanced
virulence of subgingival microbiota in smokers compared to the healthy individuals.
Further, in smokers having periodontitis, enzymes involved in cell motility and secretion,
homologous recombination, peptidase, and DNA replication were over-represented in the
subgingival microbiota compared to non-smokers with periodontitis. In a study done by
Bagaitkar et al., it has been shown that CSE significantly influences the expression of
6.8% of the P. gingivalis genome, as determined by whole genome arrays [180]. These
included genes regulating capsule and fimbriae, corresponding to the reduced proinflammatory potential of P. gingivalis; oxidative stress and DNA repair. P. gingivalis
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adapts to the environmental stress presented by CSE by altering the expression of several
genes and outer membrane proteins [180].
Despite information regarding various virulence factors of P. gingivalis and their host
interactions at the phenotypic level, the genes essential for the survival of P. gingivalis in
smokers have not been identified. In this study, we plan to identify the genes of P.
gingivalis ATCC 33277 that are essential in cigarette smoke conditioned GAM using
massively parallel sequencing technology [103, 311, 346, 347]. Due to the quantitative
nature of massively parallel sequencing, the fitness of a gene knockout can be
quantitatively determined and is a direct measure of the growth rate of the bacterial clone
containing it. The obtained information, in turn, might help us to gain information regarding
the metabolic pathways and adaptation mechanisms. Hence, the study of genes
regulating various virulence factors under the influence of cigarette smoke extract is of
interest in this project. Wwe are interested in identifying the genes necessary for the
survival of P. gingivalis in cigarette smoke-exposed GAM (Gifu anaerobic media) through
the construction and analysis of transposon mutant libraries. We further hypothesized that
we could verify conditional essentiality by the establishment of reduced relative growth of
a subset of specific bacterial mutants when competed against the parent P. gingivalis
strain under conditions of CSE-induced stress.
4.2. Materials and Methods
Materials
P. gingivalis ATCC 33277 Tnseq library generated in Chapter 3 was cultured in Gifu
anaerobe medium (GAM; Nissui Pharmaceutical, Tokyo, Japan), liquid GAM conditioned
with the cigarette smoke extract or on GAM-blood agar. Sheep blood was obtained from
Lampire Biological Laboratories (Pipersville, PA). Gentamicin, erythromycin, tetracycline,

60

ampicillin, dichloromethane, sodium sulfate and analytical nicotine standards were from
Sigma-Aldrich (St. Louis, MO). All primers were from Biosynthesis Inc. (Lewiston, TX).
Lonza flash gels came from Lonza (Rockland, ME). Wizard SV and PCR clean-up kit were
from Promega (Madison, WI). T4 DNA Ligase and buffer; MmeI; and TAE buffer came
from New England Biolabs (Ipswich, MA), while HiFi Hotstart Ready mix was from KAPA
Biosystems (Wilmington, MA) and the polymerase chain reaction (PCR) SuperMix came
from Invitrogen (Carlsbad, CA). Fast digest restriction enzymes, T4 DNA ligase, ready to
use x-gal and plasmid isolation kit came from Thermoscientific. High-efficiency
transformation neb alpha cells came from BioEngland. DNA yields were quantified using
a NanoDrop ND-1000 spectrophotometer (Wilmington, DE). We obtained P. gingivalis
strains with mutations in PGN_1524, PGN_1474, PGN_0770, PGN_0714, PGN_0491,
PGN_0287, or PGN_0088 from Dr. Richard J Lamont (University of Louisville). We
obtained P. gingivalis PGN_1200, PGN_1444, or PGN_0898 mutant strains from Dr. Jan
S Potempa (University of Louisville).
Conditioning GAM with cigarette smoke extract (CSE)
GAM was conditioned using standard reference cigarettes (2R1, Kentucky Tobacco
Research, and Development Center). By using a three-way stopcock and a syringe, GAMCSE was prepared by drawing cigarette smoke through 50 ml of the medium, with 35 ml
drags performed every 20 seconds. GAM-CSE was then filtered (0.2 mm). Nicotine
content was determined by gas-liquid chromatography and adjusted to pH 7.2 and 1000
ng/ml nicotine concentration. P. gingivalis ATCC 33277 TnSeq library was grown in their
respective control and cigarette smoke extract conditioned media under anaerobic
conditions (80% N2, 10% H2, 10% CO2) at 37°C. For all experiments, bacteria were grown
either in control or CSE conditioned media, and bacterial cells were harvested at mid to
late log phase (P. gingivalis- O.D.600 nm =1.0, corresponding to 10⁹ cells per ml)

61

Identification of essential genes for P. gingivalis survival in GAM-CSE:
a) Library passage in GAM and GAM-CSE:
P. gingivalis ATCC 33277 Tnseq mutant library aliquots described in chapter 3 were
grown in GAM (Control), and GAM-CSE containing 5 µg/ml erythromycin and 50 µg/ml
gentamycin, as P. gingivalis is naturally resistant to gentamycin and the transposon
system that is used to create mutant library has erythromycin resistance. After the cultures
reached mid-late log phase, cultures were passaged twice in GAM and GAM-CSE.
b) Preparation of DNA for TnSeq analysis:
Genomic DNA was isolated using Wizard DNA isolation kit and purified using Wizard
purification kit, as per the manufacturer’s instructions. DNA yields were quantified using a
NanoDrop ND-1000 spectrophotometer. After DNA isolation, 2 different double-stranded
DNA (dsDNA) adapter molecules were created, by using primers LIB_AdaptT_3 and
LIB_AdaptB_3 for CSE model and LIB_AdaptT_4 and LIB_AdaptB_4 for control (Table
7). The primers were combined and heated at 95°C for 5 min in a water bath and then
allowed to cool to room temperature. Then, they were aliquoted and stored at -20°C. The
genomic DNA obtained from the previous step was set for digestion with a Mme1
restriction enzyme for 1 hour at 37°C followed by for 20 min at 80°C. Then, the obtained
reactions were purified using Wizard purification kit. This purified digested DNA was then
run on 1% agarose gel and the band corresponding to approximately 1500 bp (as it
corresponds to the additive length of both transposon and the flanking sequences) was
extracted using Wizard gel extraction kit. This Mme1 digested DNA was then ligated to
barcoded adapter molecules created using T4 DNA ligase incubated for 16 h at 16°C
followed by heat inactivation for 10 min at 65°C and purified using Wizard purification kit.
This ligated purified product further amplified by performing PCR using HiFi Hotstart
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SuperMix with LIB_PCR_5 and LIB_PCR_3 primers (Table 7) using the following PCR
cycle : 98°C for 3 min, 98°C for 20 sec,60°C for 1 min,72°C for 1 min for 18x cycles and
72°C for 4 min. The obtained PCR product was purified using Wizard purification kit and
to verify the 125 bp band Lonza flash gel system was used. Further, the obtained samples
were quantified using NanoDrop ND-1000 spectrophotometer. Samples were sent to the
University of Michigan for sequencing using massively parallel sequencing technology,
Illumina HiSeq2000 platform for quantitative assessment of individual mutants in the
library by sequencing the transposon-genomic junction.
c) TnSeq Data Analysis:
CLC Bioinformatics Workbench 5.5.1 software was used to analyze the TnSeq results. In
the first step, reads having a quality score <0.05 or of <15 nucleotides were discarded.
The negative selection method was employed in order to identify the conditional essential
genes in P. gingivalis. The remaining reads were aligned to the annotated whole genome
of P. gingivalis ATCC 33277 strain. In each library, 8-14 million reads were identified with
,on average, 3900 – 6900 genes/read with 52-81% of genes having at least one hit. A total
of 258 conditional essential genes in GAM-CSE model were identified using the criteria of
>50

fold

change,

p<0.01.

DAVID

database

(david.niaid.nih.gov)

and

KEGG

(www.genome.jp/kegg) in silico analyses were used to identify the functions and
interrelationships of these identified conditional essential genes.
e) Construction of bacterial strains and plasmids:
P. gingivalis PGN_0388 deletion mutant was generated by homologous recombination, as
previously described [348]. In brief, two 1-kb flanking regions on either side of the
PGN_0388 were amplified from genomic DNA by PCR with primer pairs UF, UR and DF
and DR as shown in Table 12. The PCR product was cloned into plasmid pUC19 with an
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inserted erythromycin-resistance (erm) cassette (ermF-ermAM) from p1403CeB-H.
Correct placement and orientation of the DNA segments in the resulting pHBG3 plasmid
were confirmed by sequencing. The resulting suicide plasmid pHBG3 was electroporated
into electrocompetent P. gingivalis ATCC 33277 cells for generating the PGN_0388
mutant, as previously described [349]. Resultant clones were selected on erythromycin
plates, and double-crossover genomic recombination was confirmed by DNA sequencing
of the manipulated region.

Figure 5: The pHBG3 plasmid having ori- the origin of replication, bla – beta
lactamase gene, ermAm-ermF – erythromycin gene cassette and PGN_0388 gene
flanking regions.
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f) Competition Assays
To confirm that the selected mutant strains are specifically outcompeted by the wild-type
strain in GAM-CSE, competition assays were carried out in in vitro. P. gingivalis ATCC
33277 and mutant strains were co-cultured in 1:1 ratio in triplicates for two passages in
GAM, followed by one passage in GAM-CSE having 1000 ng/ml nicotine equivalent. When
the O.D.600 of cultures reached mid-late log phase, the GAM-CSE culture was plated on
GAM-blood agar plates with or without antibiotic (5 µg/ml of erythromycin and 5 µg/ml of
tetracycline for PGN_1200 and PGN_1444). The GAM-CSE culture was spread on the
plates in triplicate and placed in the anaerobic chamber. After incubation for seven days,
colony forming units (CFU) were determined. The ratio of the CFU on GAM-blood agar
plates with or without antibiotics was determined. The mutant strain was considered as
outcompeted by the wild-type if ≥ 2:1 ratio between wild-type and the mutant strain was
observed.
4.3. Results
The complete database of 258 identified conditional essential genes (50+ fold change,
p<0.01), in GAM-CSE is provided in Table 10. The identified genes represent
approximately 8% of the P. gingivalis ATCC 33277 genome and are presented in Figure
6 using the CGViewer software. KEGG analysis (www.genome.jp/kegg) was employed to
functionally classify the identified gene set, as noted in Table 9. Out of 258 identified
essential genes, 22 were annotated as metabolic; 1 as mismatch repair; 1 as aminoacyltRNA biosynthesis; and two as ABC transporters. The metabolic-annotated genes are
related to pyrimidine metabolism, nicotinate and nicotinamide metabolism, purine
metabolism, pentose phosphate metabolism, nitrogen metabolism, seleno-compound
metabolism, alanine aspartate and glutamate metabolism, cysteine, and methionine
metabolism. Similar functional groupings were obtained using the DAVID database
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(https://david.ncifcrf.gov/). Functional relationships between the identified conditional
essential genes were determined using KEGG analysis as shown in Figures 7a-h.
To validate the Tn-seq results, we are interested in looking at the top genes according to
fold change, and also the genes of biological significance. PGN_ 0407 (hypothetical gene),
PGN_ 0025 (spoU;rRNA methylase family protein), PGN_1494 (Oxygen-independent
coporphyrinogen III oxidase), PGN_ 0388 (Thiol peroxidase), PGN_0604 (Ferritin) are the
top hits according to the fold change. We were able to generate the PGN_0388 mutant
using site-directed mutagenesis. The other genes of biological significance are PGN_1524
encoding tyrosine kinase, PGN_1474 (luxS) encoding S-ribosyl homocysteine lyase,
PGN_1200 encoding putative ATPase,PGN_1444 (carA) encoding carbamoyl-phosphate
synthase small chain, PGN_0770 (rnz) encoding ribonuclease Z, PGN_0714 encoding
probable

pyrazinamidase/

nicotinamidase,

PGN_0491

encoding

probable

phosphotyrosine protein phosphatase, PGN_0287 (mfa1) encoding minor fimbrium
subunit Mfa1 , PGN_0088 encoding putative transcriptional regulator. These genes have
a fold change of >400 in GAM-CSE model except for PGN_1444 and PGN_0770, which
have a fold change of 172 and 108 respectively. In the competition assays, all the mutants
except PGN_1444 were outcompeted by the wild type P. gingivalis ATCC 33277 strain.
PGN_1753 was used as a control, and its growth not compromised.
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Figure 6: Gene map depicting genes essential for the survival of P. gingivalis
ATCC in GAM-CSE model (Gifu anaerobic medium conditioned with cigarette
smoke extract). Essential genes were mapped to P. gingivalis ATCC 33277
genome using CG Viewer. The blue arrows show the location of the 257 essential
genes in GAM-CSE model within the P. gingivalis 33277 chromosome. The
adjacent two rings depict gene orientation( outer and inner blue arrows represent
the positive and negative strands, respectively). The next two rings (red and
green) represent the blast hits in relation to P. gingivalis TDC60 and W 83 strains,
respectively.
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Carbohydrate Metabolism

9/86 (10%)

Nitrogen Metabolism

1/5 (20%)

Pyrimidine Metabolism

5/30 (16%)

Purine Metabolism

2/35 (5%)

Amino Acid Metabolism

9/74 (12%)

Nicotinate and Nicotinamide Metabolism

5/13 (38%)

Thiamine Metabolism

1/7 (14%)

Porphyrin Metabolism

2/30 (6%)

Folate Biosynthesis

1/9 (11%)

Aminoacyl tRNA Biosynthesis

1/4 (12%)

Mismatch Repair

1/9 (11%)

Signal Transduction

2/9 (22%)

Aminobenzoate Degradation

1/2 (50%)

Table 9: Functional classification of conditionally essential genes of P. gingivalis
in GAM-CSE based on KEGG analysis.
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Figure 7a: Pyrimidine Metabolism (pathway enriched among conditional essential
P. gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 11.
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Figure 7b: Purine Metabolism (pathway enriched among conditional essential P.
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 11.
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Figure 7c: Nicotinate and Nicotinamide Metabolism (pathway enriched among
conditional essential P. gingivalis genes in GAM-CSE). KEGG pathways
(www.genome.jp/kegg) are presented with the proteins catalyzing each step
shown by their enzyme commission number and substrates/products. Green
shading indicates the presence of homologs in P. gingivalis. The red star denotes
essential genes. The PGN assignments of the essential metabolic genes are
provided in Table 11.
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Figure 7d: Mismatch Repair (pathway enriched among conditional essential P.
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 11.
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Figure 7e: Aminoacyl tRNA Biosynthesis (pathway enriched among conditional
essential P. gingivalis genes in GAM-CSE). KEGG pathways
(www.genome.jp/kegg) are presented with the proteins catalyzing each step
shown by their enzyme commission number and substrates/products. Green
shading indicates the presence of homologs in P. gingivalis. The red star denotes
essential genes. The PGN assignments of the essential metabolic genes are
provided in Table 11.
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Figure 7f: Nitrogen Metabolism (pathway enriched among conditional essential P.
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are
presented with the proteins catalyzing each step shown by their enzyme
commission number and substrates/products. Green shading indicates the
presence of homologs in P. gingivalis. The red star denotes essential genes. The
PGN assignments of the essential metabolic genes are provided in Table 11.
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Figure 7g: Selenocompound Metabolism (pathway enriched among conditional
essential P. gingivalis genes in GAM-CSE). KEGG pathways
(www.genome.jp/kegg) are presented with the proteins catalyzing each step
shown by their enzyme commission number and substrates/products. Green
shading indicates the presence of homologs in P. gingivalis. The red star denotes
essential genes. The PGN assignments of the essential metabolic genes are
provided in Table 11.
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Figure 7h: Alanine, Aspartate and Glutamate Metabolism (pathway enriched
among conditional essential P. gingivalis genes in GAM-CSE). KEGG pathways
(www.genome.jp/kegg) are presented with the proteins catalyzing each step
shown by their enzyme commission number and substrates/products. Green
shading indicates the presence of homologs in P. gingivalis. The red star denotes
essential genes. The PGN assignments of the essential metabolic genes are
provided in Table 11.
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Table 10: Gene list of the conditional essential genes identified in GAM-CSE
model (n=258).
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Pathways

Number of
genes
identified

Genes identified

Pyrimidine metabolism

6

PGN_0375
PGN_1158
PGN_1412
PGN_1443
PGN_1444
PGN_1999

Nicotinate and nicotinamide
metabolism

7

PGN_0533
PGN_0534
PGN_0714
PGN_1120
PGN_1121
PGN_1122
PGN_1412

Purine metabolism

1

PGN_1412

Pentose phosphate metabolism

1

PGN_1941

Nitrogen metabolism

1

PGN_1746

Seleno-compound metabolism

1

PGN_1618

Alanine aspartate and glutamate
metabolism

2

PGN_1443
PGN_1444

Cysteine and methionine
metabolism

3

PGN_1475
PGN_1618
S-ribosyl homocysteine
lyase

Mismatch repair

1

PGN_1581

Aminoacyl-tRNA biosynthesis

1

PGN_1646

ABC transporters

2

PGN_0707
PGN_0857

Table 11: Summary of the genes identified in different pathways using KEGG
analysis.
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UF

gagcgaattCCATCAGCATCCCTGTAGTG

UR

CCAAACTCGCTCTCCAGCTAAAcagctgatag

DF

gatatctagaCATTGGCACAGCCCCGATTCC

DR

CCAAACTCGCTCTCCAGCTAAAcagctgatag

Table 12: Primers used for mutant construction.
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4.4. Discussion
P. gingivalis, a Gram-negative periodontal pathogen, must overcome the environmental
stress in the periodontal pocket for its survival and growth. Bacterial adaptation to
environmental cues involves elaborate regulation of several mechanisms [124]. We were
interested in identifying conditionally essential genes for P. gingivalis survival in GAMCSE, using the generated P. gingivalis ATCC 33277 Tn-seq library. We identified 258
essential genes for P. gingivalis survival in GAM-CSE. These identified genes account for
8% of genes in P. gingivalis ATCC 33277 genome.
PGN_0714 encodes a protein, probable pyrazinamidase/nicotinamidase, involved in the
nicotinate and nicotinamide metabolism – redox reaction, thus protecting the bacteria from
the oxidative stress induced by cigarette smoke. PGN_1524 encodes a tyrosine kinase
which is required for secretion of extracellular polysaccharide and biofilm formation with
S. gordonii [350]. Bacterial kinases have also been shown to be involved in stress
responses, antibiotic resistance, and DNA metabolism [351-353]. PGN_0088 (sinR),
encodes putative transcriptional regulator sinR involved in sequence-specific DNA
binding. sinR ortholog PGN_0088 inhibits polysaccharide synthesis and affects the
structure of EPS in P. gingivalis ATCC 33277 biofilms [354]. Further, sinR mutation
resulted in increased production of exopolysaccharide, leading to increased resistance to
physical disruption [354]. PGN_1444 encodes a protein involved in pyrimidine biosynthetic
pathway and glutamine and arginine metabolic processes. PGN_1200 encodes a protein
involved in DNA replication and repair. PGN_0491 (Ltp1) encodes phosphotyrosine
protein phosphatase probable phosphotyrosine protein phosphatase, which regulates the
expression of luxS and exopolysaccharide synthesis, which play a significant role in biofilm
formation[355]. PGN_0287 (mfa1), encodes minor fimbrium subunit mfa1. mfa1 is
involved in bacterial attachment to the host cell surface and other bacteria. Thus, mfa1

80

mediates biofilm formation [356-358]. The competition assay results of the genes
described so far provide insight into the gene fitness of genes of interest in the GAM-CSE
model, to promote P. gingivalis growth in media conditioned with cigarette smoke, which
may have relevance in infection and colonization in vivo.
Also in the GAM-CSE model, genes involved in carbohydrate and amino acid metabolism;
ABC transporters were identified as essential genes. The major habitat of P. gingivalis is
the subgingival sulcus in the oral cavity. It relies on the fermentation of amino acids for
energy production when sugar availability is low [359]. Also, P. gingivalis serves as a
secondary colonizer of dental plaque, often adhering to primary colonizers such as S.
gordonii and Prevotella intermedia. ABC transporter genes are believed to provide
resistance to P. gingivalis from potentially harmful chemicals in cigarette smoke [180].
Several genes encoding nucleotide, energy, cofactors and vitamin metabolism;
translation, replication, and repair were also identified as essential genes in GAM-CSE
model. Replication and repair genes protect bacteria from damage as a result of the
oxidative stress induced by cigarette smoke.
Future studies using site-directed mutagenesis of top genes according to fold change in
the GAM-CSE model, and complementation assays of the mutants, can be done to
further confirm and identify the genes unique to GAM-CSE model. Data generated would
provide a better understanding of specific genes, as well as developing novel variants of
genes of interest. In summary, despite reduced clinical inflammation, smokers are more
prone to bacterial infection and to develop periodontitis. Our experimental results
identified several genes essential for P. gingivalis growth and survival when exposed to
cigarette smoke. Similar analyses can be carried out in other P. gingivalis strains, which
in turn may provide insight into the common strategies among many bacteria. Apart from
smoking, the TnSeq library can be tested under other conditions relevant to periodontal
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diseases, including abscess, biofilm, and TIGK invasion models. In the long-term similar
analyses, under different conditions and on other bacterial pathogens, to distinguish
between inherently essential and conditionally essential genes, may reveal additional
targets for new therapeutics.
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CHAPTER 5
SUMMARY
Periodontal diseases are multifactorial. In this study, we focused on the relationship
between gestational diabetes mellitus and oral infection with periodontopathogens, and
the influence of each on systemic inflammation in pregnant women. Also, we focused on
identification of P. gingivalis ATCC 33277 inherently essential genes and conditional
essential genes in media conditioned with cigarette smoke.
Gestational diabetes mellitus is a significant risk factor for periodontal diseases.
Pregnancy gingivitis is associated with a hormonal imbalance in the pregnant women. As
stated earlier, in this study we are interested in the microbiological aspect of gingivitis in
pregnant women. It has been found that the gingivitis during pregnancy was associated
with the increased oral infection with P. gingivalis, F. alocis, and T. denticola and
combinations of the three. Gestational diabetes mellitus was also associated with
increased infection with individual and multiple periodontopathogens. An interesting
finding observed in our study is that it is the gingivitis, rather than GDM, that is the driving
force for the increased systemic inflammation in pregnant women.
We successfully generated a P. gingivalis ATCC 33277 transposon library covering a wide
range of the genome which enabled us to identify the inherently essential genes in P.
gingivalis ATCC 33277 strain. Further, we compared the generated library with the existing
library (Klein et al., 2012) in order to identify the common inherently essential genes. We
entered the identified inherently essential genes in DEG database, which has only 36
bacterial essential genes apart from P. gingivalis. As the database grows, we can compare
the obtained inherently essential gene list to essential gene list of other bacteria. This
comparison, in turn, will help us to identify the species specific essential genes and also
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essential genes common in many bacterial species. These identified genes might serve
as new therapeutic targets to combat P. gingivalis specific infection or to control several
infections at the same time. Further, the P. gingivalis ATCC 33277 transposon library can
be tested under variable conditions such as cigarette smoke, invasion model and mouse
models to identify the conditional essential genes.
Cigarette smoke is an important environmental modifiable risk factor for periodontal
diseases. Despite reduced clinical signs of periodontal inflammation in smokers, cigarette
smoke is known to increase periodontal pathogen infection. The exact reason for the
increased periodontal pathogen infection is unclear. For periodontal pathogens, such
as P. gingivalis to induce or exacerbate periodontal diseases in smokers, they must first
be able to survive the highly complex composite toxic insult represented by cigarette
smoke. While P. gingivalis is resistant to very high doses of cigarette smoke and tobacco
constituents, the survival mechanisms are entirely unknown. We identified conditional
essential genes for P. gingivalis survival in GAM-CSE, which are involved in several
metabolic pathways, which enable P. gingivalis to combat the stress induced by cigarette
smoke. Apart from the genes involved in metabolic processes, several genes involved in
P. gingivalis attachment to host tissues and other bacterial species were also identified in
GAM-CSE model. The genes identified so far are from several studies that have shown
increased homotypic and heterotypic biofilm formation by P. gingivalis under the influence
of cigarette smoke [157, 197, 360]. These findings support the idea of increased
periodontal pathogen infection in smokers as a result of the dysbiotic influence of P.
gingivalis.
From the above studies, we can state that oral pathogens drive the systemic inflammation
in pregnant women and, also that P. gingivalis adapts to environmental cues. It can also
be inferred that these adaptations are essential to enabling its survival. Further, adaptive
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mechanisms may also promote bacterial interaction with other oral pathogens, which in
turn might lead to periodontal destruction.
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APPENDIX A
PUBLICATION REUSE LICENSES

Figure A.1: License for the reuse of “Increased infection with key periodontal
pathogens during gestational diabetes mellitus.”
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Figure A.2: License for the reuse of “Comparison of inherently essential genes
of Porphyromonas gingivalis identified in two transposon-sequencing libraries.”
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